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countries, 2000–17: analysis for the Global Burden of Disease 
Study 2017
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Summary
Background Across low-income and middle-income countries (LMICs), one in ten deaths in children younger than 
5 years is attributable to diarrhoea. The substantial between-country variation in both diarrhoea incidence and 
mortality is attributable to interventions that protect children, prevent infection, and treat disease. Identifying 
subnational regions with the highest burden and mapping associated risk factors can aid in reducing preventable 
childhood diarrhoea.
Methods We used Bayesian model-based geostatistics and a geolocated dataset comprising 15 072 746 children 
younger than 5 years from 466 surveys in 94 LMICs, in combination with findings of the Global Burden of Diseases, 
Injuries, and Risk Factors Study (GBD) 2017, to estimate posterior distributions of diarrhoea prevalence, incidence, 
and mortality from 2000 to 2017. From these data, we estimated the burden of diarrhoea at varying subnational levels 
(termed units) by spatially aggregating draws, and we investigated the drivers of subnational patterns by creating 
aggregated risk factor estimates.
Findings The greatest declines in diarrhoeal mortality were seen in south and southeast Asia and South America, 
where 54·0% (95% uncertainty interval [UI] 38·1–65·8), 17·4% (7·7–28·4), and 59·5% (34·2–86·9) of units, 
respectively, recorded decreases in deaths from diarrhoea greater than 10%. Although children in much of Africa 
remain at high risk of death due to diarrhoea, regions with the most deaths were outside Africa, with the highest 
mortality units located in Pakistan. Indonesia showed the greatest within-country geographical inequality; some 
regions had mortality rates nearly four times the average country rate. Reductions in mortality were correlated to 
improvements in water, sanitation, and hygiene (WASH) or reductions in child growth failure (CGF). Similarly, most 
high-risk areas had poor WASH, high CGF, or low oral rehydration therapy coverage.
Interpretation By co-analysing geospatial trends in diarrhoeal burden and its key risk factors, we could assess 
candidate drivers of subnational death reduction. Further, by doing a counterfactual analysis of the remaining disease 
burden using key risk factors, we identified potential intervention strategies for vulnerable populations. In view of the 
demands for limited resources in LMICs, accurately quantifying the burden of diarrhoea and its drivers is important 
for precision public health.
Funding Bill & Melinda Gates Foundation.
Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 
license.
Introduction
Across low-income and middle-income countries 
(LMICs), diarrhoea causes more than half a million 
childhood deaths annually.1 In addition to this staggering 
loss of life, more than 910 million childhood cases of 
diarrhoea per year2 are distributed unequally across the 
population, causing not only acute morbidity but also 
long-term disability in children who suffer repeatedly 
with enteric infections.3 National-level analyses of the 
burden of childhood diarrhoea, measured by both death 
rates and incidence, have exposed substantial variation. 
In LMICs in 2017, the incidence of diarrhoea ranged 
from less than one episode per child per year to more 
than four episodes per child per year.2 In the same 
population, the case-fatality rate of diarrhoea can vary 
from one per 10 000 infections to more than 20 per 
10 000 infections.4
WHO’s integrated Global Action Plan for Pneumonia 
and Diarrhoea (GAPPD) identified three approaches to 
reduce the burden of diarrhoea: protect, prevent, and 
treat.5 Healthy children are less likely to have severe 
diarrhoea episodes,6 so diarrhoeal burden can be reduced 
by prioritising good health practices from birth. As such, 
reducing general health risk factors, such as child growth 
failure (CGF) indicators of stunting, wasting, and under-
weight,4,7 can protect a child from diarrhoea. Preventing 
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illness by promoting vaccination and improved water, 
sanitation, and hygiene (WASH) can similarly reduce 
diarrhoeal burden.8,9 Finally, appropriate treatment, such 
as oral rehydration solution (ORS), the efficacy of which 
exceeds 90%,10 can substantially reduce death resulting 
from disease-associated dehydration.11,12
Distal determinants of diarrhoeal mortality, such as 
measurable indicators of child welfare,13 have been 
geospatially mapped at the local level in Africa, including 
under-5 mortality,14 CGF,15 and education levels of the 
broader population.16 Country-level assessment of these 
determinants can mask subnational variation and provide 
limited information with which to formulate policy.17 
Furthermore, mapping interventions such as malaria 
nets18 and vaccines19 has shown the positive effects of these 
strategies on reducing diseases. Subsequently, precise 
mapping of diarrhoea-related interventions, including 
ORS coverage20 and access to safe water and sanitation 
(Deshpande A, unpublished data), in addition to diarrhoea 
incidence and death, provides in-depth analysis to aid in 
the prevention of deaths associated with diarrhoea.
National trends in diarrhoeal burden are associated 
with (and in many cases driven by) national trends in 
risk factors associated with the protect, prevent, and treat 
strategy. Childhood stunting, poor sanitation access, and 
low ORS coverage are risk factors most strongly asso-
ciated with changes in diarrhoeal burden.4 To date, no 
comprehensive attempt has been made to quantify either 
the subnational variation in diarrhoea or these key risk 
factors across LMICs. Several isolated studies of sub-
national variation in diarrhoea,21 childhood stunting,15 
WASH,22 and ORS coverage23 have shown striking 
variation at the spatial scale investigated. However, 
without estimates designed to be comparable across 
space and time, it is difficult to analyse such scattered 
information as a cohesive body of knowledge.
Reducing morbidity and mortality could be accom-
plished by targeting regions with the highest mortality 
rate, or those with the greatest total number of deaths. At 
the national scale, for example, Central African Republic 
was estimated to have the highest childhood mortality 
rate attributable to diarrhoea globally, at 6·9 deaths per 
1000 children. Because of this country’s relatively small 
population, however, this rate translates to approximately 
4156 children dying per year.21 By contrast, in Nigeria, 
which has a much larger population than Central African 
Republic, an estimated 104 000 children a year die from 
diarrhoea, but the mortality rate is less than half that of 
Central African Republic (3·0 deaths per 1000 children).24 
A location within a country could have a relatively low 
risk of mortality but a sufficiently large population so it is 
a greater contributor to overall burden than other areas 
in that country. Thus, decisions aimed at optimum 
burden reduction might overlook those at highest risk. 
Mapping both rates and counts can aid in the design of 
intervention strategies that efficiently save lives while 
Research in context
Evidence before this study
In the Global Burden of Diseases, Injuries, and Risk Factors Study 
(GBD) 2017, diarrhoea was the third leading cause of death 
among children younger than 5 years and was reported to have 
caused an estimated 534 000 deaths. WHO’s integrated Global 
Action Plan for the Prevention and Control of Pneumonia and 
Diarrhoea calls for protection of children from disease by 
establishing good health practices, preventing infection from 
occurring, and treating infections when they occur. Over the 
past decade, large reductions in childhood mortality due to 
diarrhoea have been recorded across low-income and 
middle-income countries (LMICs), in part attributable to 
strategies to reduce child growth failure (CGF), improve water, 
sanitation, and hygiene (WASH), and increase access to oral 
rehydration therapy and vaccines. Several studies have recorded 
substantial between-country variation in both the likelihood of 
a child experiencing a diarrhoea episode and that episode 
resulting in death. To reduce the burden of childhood diarrhoea, 
the remaining subnational regions with the highest prevalence 
and those with the lowest levels of interventions should be 
identified.
Added value of this study
We present the first high-resolution subnational estimates of 
diarrhoeal morbidity and mortality from 2000 to 2017 in LMICs. 
We used Bayesian model-based geostatistics and an extensive 
geolocated dataset in combination with established methods 
from GBD 2017 for both burden estimation and risk factor 
association. We did a systematic assessment of local variation to 
estimate the distribution of diarrhoea prevalence, incidence, 
and mortality. Our estimates show considerable subnational 
variation in the diarrhoeal burden for children younger than 
5 years. We synthesised new subnational estimates of the key risk 
factors of diarrhoea to discern averted deaths attributable to 
improvements in these drivers of diarrhoeal morbidity and 
mortality. Finally, when focusing on subnational regions with the 
highest remaining burden, we identified not only which regions 
of the world have the highest diarrhoeal burden and continued 
geographical inequalities but also the subnational risk factors 
that require targeted interventions to alleviate this burden.
Implications of all the available evidence
By providing estimates of remaining diarrhoeal burden at 
various spatial scales, we have identified countries and locations 
that are still most in need of preventive and protective 
measures. Our results indicate that regions with the highest 
burden had varied exposure to select risk factors; however, 
similar to previous studies, most high-burden areas showed 
some combination of poor WASH, high CGF, and low oral 
rehydration solution coverage. In view of the limited resources 
in many LMICs, quantification of both the local burden of 
diarrhoea and its drivers is important to maximise impact.
Articles
www.thelancet.com   Published online May 6, 2020   https://doi.org/10.1016/S0140-6736(20)30114-8 3
also highlighting entrenched geographical disparities in 
diarrhoeal burden.
Here, we present an analysis of local variation in 
diarrhoeal morbidity and mortality in children younger 
than 5 years across 94 LMICs between 2000 and 2017. 
We used Bayesian model-based geostatistics and an 
extensive geolocated dataset (describing 3 738 327 diar-
rhoea episodes across 15 072 746 children) in combination 
with methods from the Global Burden of Diseases, 
Injuries, and Risk Factors Study (GBD) 2017 to esti-
mate posterior distributions of continuous continent-
wide surfaces of diarrhoea prevalence, incidence, and 
mortality.1,2 We then aggregated our estimates at second 
administrative-level units (eg, districts in Uganda or 
divisions in Kenya; henceforth referred to as units), to 
identify regions with the most pronounced rate of 
burden reduction versus those that continue to have 
higher-than-average burden. We combined this analysis 
with published estimates of subnational CGF variation15 
and new estimates of subnational variation in WASH 
(Deshpande A, unpublished data) and ORS20 to break 
down diarrhoeal burden. Finally, through these linked 
analyses, we identified regions most in need of tailored 
interventions to reduce the burden of this largely 
preventable disease.
Methods
Definitions
Diarrhoea episodes were defined as three or more loose 
stools over a 24-h period.4 Diarrhoea prevalence was defined 
as the point prevalence of children younger than 5 years 
with diarrhoea. Incidence was defined as the number of 
cases of diarrhoea in children younger than 5 years per 
child per year. Mortality was defined as the number of 
deaths among children younger than 5 years due to 
diarrhoea per child per year. Rates per 1000 are presented in 
the figures and represent prevalence, incidence, or 
mortality rates per child multiplied by 1000). Diarrhoea 
burden is used throughout this Article to refer to the 
combined burden of prevalence, incidence, and mortality.
Data
We included 94 LMICs in our analysis; these countries 
were defined according to the Socio-demographic Index 
(SDI), which assesses development based on education, 
fertility, and income.24 Where appropriate, we use 
designated ISO 3166-1 alpha-3 codes for countries. Our 
study complies with the Guidelines for Accurate and 
Transparent Health Estimates Reporting (GATHER) 
recommendations (appendix 1 pp 84–85).25
Surveys
We compiled 466 household surveys (including the 
Demographic and Health Survey [DHS], Multiple 
Indicator Cluster Survey [MICS], and other country-
specific surveys) from 2000 to 2017 with geocoded 
information from 207 021 coordinates corresponding 
to survey clusters and 17 954 subnational polygon 
boundaries. We included surveys that asked if children 
younger than 5 years had diarrhoea, typically within the 
preceding 2 weeks. Potential bias attributable to seasonal 
variation in diarrhoea was addressed, as described in 
appendix 1 (p 5). Data were vetted for representativeness 
at the national level and subnational level, as appropriate. 
Data inclusion, coverage, and validation are further 
described in appendix 1 (pp 3, 9).
Spatial covariates
We compiled 15 covariates that were indexed at the 
subnational level and could possibly be related to diarrhoea 
prevalence, including access to roads, ratio of child 
dependents (aged 0–14 years) to working-age adults (aged 
15–64 years), distance from rivers or lakes, night-time 
lights (time-varying covariate), elevation, population ratio 
of women of maternal age to children, population (time-
varying covariate), aridity (time-varying covariate), urban 
or rural (time-varying covariate), urban proportion of the 
location (time-varying covariate), irrigation, number of 
people whose daily vitamin A needs could be met, preva-
lence of under-5 stunting (time-varying covariate), 
prevalence of under-5 wasting (time-varying covariate), 
and diphtheria-tetanus-pertussis immunisation coverage 
(time-varying covariate). We also included the Healthcare 
Access and Quality Index,26 percentage of the population 
with access to improved toilet types, and percentage of 
the population with access to improved water sources 
(as defined by WHO and UNICEF’s Joint Monitoring 
Programme) as national-level time-varying covariates. 
We filtered these covariates for multicollin earity in each 
modelling region (appendix 1 pp 5–6) using variance 
inflation factor (VIF) analysis with a VIF threshold of 3.27 
Covariate information, including plots of all covariates, is 
detailed in the appendix 1 (pp 25–26, 90–96).
Statistical analysis
Geostatistical model
Prevalence data were used as inputs to a Bayesian model-
based geostatistical framework. Briefly, this framework 
uses a spatially and temporally explicit hierarchical 
logistic regression model to predict prevalence. Potential 
interactions and non-linear relations between covariates 
and diarrhoea prevalence were incorporated using a 
stacked generalisation technique.28 Posterior distributions 
of all parameters and hyperparameters were estimated 
using R-INLA version 19.05.30.9000.29,30 Uncertainty was 
calculated by taking 250 draws from the estimated posterior 
joint distribution of the model, and each uncertainty 
interval (UI) reported represents the 2·5th and 97·5th 
percentiles of those draws. Models were run independently 
in 14 geogra phically distinct modelling regions based on 
the GBD 2010 study,31 and one country-specific model in 
India. Analyses were done using R version 3.5.0. Maps 
were produced using ArcGIS Desktop 10.6. Additional 
details are provided in appendix 1 (pp 6–8).
See Online for appendix 1
For the Joint Monitoring 
Programme see 
https://washdata.org/
For more on R see 
https://r-project.org
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Figure 1: Mapping of 
diarrhoea incidence among 
children younger than 
5 years in low-income and 
middle-income countries by 
second administrative-level 
unit, 2017
Estimated mean incidence rate 
per 1000 children in 2017 (A). 
Absolute deviation from mean 
incidence rate by country 
in 2017 (B). Annualised 
decrease in diarrhoea 
incidence rate from 2000 to 
2017 (C). Estimated mean 
number of cases of diarrhoea 
among children in 2017 (D). 
All panels are aggregated to 
the second administrative-
level unit. Maps reflect 
administrative boundaries, 
land cover, lakes, 
and population; grey-coloured 
grid cells were classified as 
barren or sparsely vegetated 
and had fewer than ten people 
per 1 × 1 km grid cell, or were 
not included in these 
analyses.33–38
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Post estimation
Estimated prevalence was converted into incidence 
using an average duration of a diarrhoea episode of 
4·2 days4 (appendix 1 p 9). We converted incidence 
surfaces to mortality surfaces by multiplying the 
incidence values by country-specific and year-specific 
case-fatality rates (which did not vary subnationally). 
We calibrated our continuous prevalence estimates to 
those of prevalence, mortality, and incidence from 
GBD 2017. However, we did not calibrate prevalence or 
incidence in South Africa because of unreasonably low 
estimates in this location in the GBD 2017 study. We 
then calculated population-weighted aggregations of 
the 250 draws of diarrhoea prevalence, mortality, and 
incidence estimates at the country level, first admin-
istrative-level unit, and second administrative-level unit 
(hereafter referred to as unit). This calculation resulted 
in estimates for 24 143 units within 94 countries. 
Geographical inequalities were quantified as the relative 
difference between each unit and the respective country 
average. We also estimated inequality using the Gini 
coefficient,32 which summarises the distribution of 
each indicator across the population, with a value 
of 0 representing perfect equality and 1 representing 
maximum inequality (appendix 1 p 12).
Counterfactual analyses using diarrhoea risk factors
Following the GAPPD framework, we did a post-hoc 
counterfactual analysis using subnational estimates of 
risk factors according to GBD 2017, including reducing 
prevalence of childhood stunting and childhood wasting 
(protect), access to improved sanitation and improved 
water (prevent), and increasing ORS coverage (treat). 
Some known diarrhoea risk factors (eg, low coverage of 
rotavirus vaccine, or no or partial breastfeeding) were 
not included because subnational estimates are currently 
not available for all 94 LMICs included in this study. 
We used the counterfactual analysis to estimate the 
number of deaths averted because of changes in CGF 
and WASH risk factors (appendix 1 pp 61–62).
Model validation
Models were validated using source-stratified five-fold 
cross validation. Holdout sets were created by combining 
randomised sets of second administrative unit cluster-
level datapoints. Model performance was summarised 
by the bias (mean error), total variance (root-mean-
square error), 95% data coverage within prediction 
intervals, and correlation between observed data and 
predictions. When possible, estimates were compared 
against existing estimates. All validation procedures 
and corresponding results are provided in appendix 1 
(p 9).
Role of the funding source
The funder had no role in study design, data collection, 
data analysis, data interpretation, or writing of the 
report. RCR had full access to all data in the study and 
had final responsibility for the decision to submit for 
publication.
Results
Our model produced estimates of local diarrhoea 
prevalence, incidence, and mortality for 94 LMICs yearly 
from 2000 to 2017, showing subnational spatial and 
temporal variation. A large variation in diarrhoeal burden 
was seen, both between and within countries, and striking 
differences in trends were noted over time by location. 
Although, in many countries, rates of diarrhoeal morbidity 
and mortality were disproportionally high in less-populated 
rural areas, the absolute burden of diarrhoeal mortality 
was typically concentrated in highly populated urban 
centres. By integrating these subnational estimates of 
mortality with similar estimates of leading risk factors, 
improvements in WASH (Deshpande A, unpublished 
data) and prevention of CGF (relative to levels in 2000) 
were estimated to avert 46 000 (95% UI 32 000–170 000) 
and 245 000 (177 000–940 000) child deaths in 2017, respec-
tively. The full array of our model outputs is provided in 
appendix 2 (pp 1–950), and online.
Incidence of diarrhoea
In 2017, Yemen had the most units exceeding five cases of 
diarrhoea per child per year (124 units), with Afghanistan 
(16 units) the only other country with such high incidence 
(figure 1A). It is unsurprising that Yemen had the most 
subnational units with high incidence, because the 
country had had the highest national incidence of 
diarrhoea globally, with 4·7 (95% UI [4·0–5·7]) cases per 
child per year. In 2017, the highest incidence of diarrhoea 
for sub-Saharan Africa was in Cameroon (4·8 [95% UI 
2·9–7·4] cases per child per year in Mayo-Danay depart-
ment, Extrême-Nord); for Latin America the highest 
incidence was in Guatemala (4·7 [3·7–5·8] cases per child 
per year in San Antonio Suchitepéquez department, 
Suchitepéquez; and 4·4 [3·5–5·5] cases per child per year 
in San Miguel Panán department, Suchitepéquez); and 
for southeast Asia the highest incidence of diarrhoea was 
in Papua New Guinea (3·5 [2·7–4·5] cases per child per 
year in Koroba-Kopiago district, Hela). Massive variation 
within regions is exemplified in central Asia and south 
Asia, where the highest incidence of diarrhoea by country 
spanned from 2506th to 24 391st across all LMICs 
(2·8 [95% UI 2·1–3·6] cases per child per year in Moskva 
district, Khatlon, Tajikistan; and 0·7 [0·4–1·3] cases per 
child per year in Aşgabat district, Aşgabat, Turkmenistan; 
figure 1A). Maps of upper and lower bounds for the 
uncertainty on incidence can be found in appendix 1 (p 47).
As with variation between countries, substantial 
variation was seen within most countries. 16 countries 
had at least one unit with an estimated incidence of 
diarrhoea more than 1·0 case per child per year higher 
than the national average (figure 1B). The district of 
Darqad, Takhar, Afghanistan, had an incidence of 
For the full array of model 
outputs see https://preview.
healthdata.org/lbd/diarrhoea
See Online for appendix 2
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A
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Absolute deviation from 
country mean (per 1000)
<–1·0 –0·5 0 0·5 >1·0
Annualised decrease in 
diarrhoea mortality (%)
0 3·6 7·5 11·5 >15·0
Diarrhoea mortality rate
(per 1000)
0 0·1 1·0 4·0 >7·0
Diarrhoea mortality count 
10 >10000
Figure 2: Mapping of 
diarrhoeal mortality among 
children younger than 
5 years in low-income and 
middle-income countries by 
second administrative-level 
unit, 2017
Estimated mean mortality rate 
per 1000 children in 2017 (A). 
Absolute deviation from the 
mean mortality rate by 
country in 2017 (B). 
Annualised decrease in 
diarrhoeal mortality rate 
from 2000 to 2017 (C). 
Estimated mean number of 
diarrhoeal deaths among 
children in 2017 (D). All panels 
are aggregated to the second 
administrative-level unit. 
Maps reflect administrative 
boundaries, land cover, lakes, 
and population; grey-coloured 
grid cells were classified as 
barren or sparsely vegetated 
and had fewer than ten people 
per 1 × 1 km grid cell, or were 
not included in these 
analyses.33–38
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6·3 (95% UI 4·2–9·5) cases per child per year, which was 
2·3 cases per child per year higher than the national 
average (4·0 [2·8–5·3] cases per child per year). 
Conversely, only nine countries had units with incidence 
less than 1·0 case per child per year lower than their 
country average (appendix 2 pp 3–4, 478–950). Countries 
with large relative geographical inequality include 
Guyana, where the rate in the Marudi council, Upper 
Takutu-Upper Essequibo, was 2·4 (95% UI 2·0–3·1) 
cases per child per year, which is much higher than the 
country average of 1·2 (0·9–1·5) cases per child per year. 
It is important to note that the comparison in Afghanistan 
also illustrates a technical difficulty in sum marising 
correlated uncertainty. In Afghanistan, the 95% UI for 
the estimated incidence of diarrhoea in Darqad overlaps 
that for average incidence across the country, but these 
UIs are based on summarising aggregations from 
draws of correlated incidence surfaces. In every draw 
from the posterior distribution of incidence, Darqad had 
an incidence at least 86·0% higher than that draw’s 
estimated country incidence.
The substantial reduction in overall diarrhoeal burden 
since 2000 has not translated into a consistent reduction 
in incidence of diarrhoea. 5729 (24%) of 24 139 units 
had an increase in childhood diarrhoea incidence 
from 2000 to 2017 (figure 1C). Laos in particular 
contained 24 units with annual rates of change in 
diarrhoea incidence exceeding 5% per year. Conversely, 
among all units that had decreases in incidence, Nigeria 
saw the greatest number of units (n=40) with annual 
declines in diarrhoea incidence of 7% or more.
Incidence data provide information on the per person 
risk of disease. However, some units with the highest 
incidence of diarrhoea are sparsely populated. On the 
other hand, many units with the highest incidence 
of diarrhoea and moderate rates of diarrhoea have 
considerable populations. For example, in 2017, five units 
in Punjab, Pakistan (Dera Ghazi Khan, Faisalabad, 
Gujranwala, Lahore, and Multan) were estimated to have 
more than 21 (95% UI 14·8–28·9) million cases of 
diarrhoea in children younger than 5 years (figure 1D). 
Each of these units had an incidence less than 
1·9 (95% UI 1·3–3·0) cases per child per year. By 
contrast, Wadhrah district in Hajjah, Yemen, had a 
high inci dence of diarrhoea (5·5 [95% UI 4·3–7·0] 
cases per child per year), but because of this district’s 
relatively small child population, there were only 
9890 (7766–12 723) cases of diarrhoea (figure 1D). These 
incidence data suggest that interventions focused on 
lowering the absolute burden of diarrhoea might best be 
focused on urban areas, although this focus risks 
exacerbating existing geographical disparities.
Mortality from diarrhoea
Similar to patterns noted previously on a subnational 
map of diarrhoeal mortality in Africa,21 substantial 
diarrhoeal burden was seen in several countries in the 
Sahel region of Africa, with Birao in Vakaga, Central 
African Republic, having the highest mortality rate glob-
ally of 8·2 (95% UI 6·8–9·7) deaths per 1000 children in 
2017 (figure 2A). Seven countries had at least one unit 
exceeding five deaths per 1000 children, and all were 
located in Africa. For 46 countries, the GAPPD goal of 
decreasing childhood diarrhoeal mortality to less than 
A Indonesia, 2000
B Indonesia, 2017
C DPeru, 2000 Peru, 2017
–100 0 50 150 >300
Relative deviation from 
country mean (%)
Figure 3: Relative geographical inequality of childhood diarrhoeal mortality in Indonesia and Peru in 2000 
and 2017
Relative deviation of second administrative-level units from country mean for Indonesia in 2000 (A), Indonesia 
in 2017 (B), Peru in 2000 (C), and Peru in 2017 (D). Maps reflect administrative boundaries, land cover, lakes, 
and population; grey-coloured grid cells were classified as barren or sparsely vegetated and had fewer than 
ten people per 1 × 1 km grid cell, or were not included in these analyses.33–38
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one death per 1000 children was achieved in every 
second administrative-level unit by 2017 (appendix 2 
pp 5–477). Global variation in diarrhoea mortality was so 
vast that rates for many countries remain several orders 
of magni tude lower than those in central sub-Saharan 
Africa (figure 2A).
Similar to incidence, substantial within-country vari-
ation was noted in diarrhoeal mortality. As previously 
highlighted in our Africa-focused analysis,21 some units 
in Nigeria in 2017 were far above the country average. 
Of the 100 largest deviations above the national mean 
mortality rate, 86 occurred in northern Nigeria (figure 2B). 
Only units in Chad, Kenya, and Nigeria had rates greater 
than one death per 1000 less than their country average 
mortality rate (figure 2B). When the analysis was done 
in terms of relative deviation from the mean, different 
patterns of subnational variation became apparent. 
Indonesia stood out as having many units within Papua 
that were more than three-fold the country average; in 
particular, the Boven Digoel Regency of Papua, Indonesia, 
was estimated to have a diarrhoeal mortality rate 3·4 times 
the national average (figures 3A, B). Similarly, 736 units 
of Mexico were estimated to have mortality rates more 
than double the national average (figure 2B). Although 
Nigeria had massive absolute deviations, units with the 
highest absolute deviations were 169·0% (95% UI 
114·2–256·5) the national average (figure 2B). Maps of 
upper and lower bounds for uncertainty on incidence 
can be found in appendix 1 (p 48).
Unlike incidence of diarrhoea, diarrhoeal mortality 
declined in most units from 2000 to 2017. 8658 (36%) of 
24 143 units showed reduced rates of childhood diarrhoeal 
mortality, by more than 10% per year (figure 2C). The 
greatest declines in diarrhoeal mortality were seen in 
south and southeast Asia and South America, where 
54·0% (95% UI 38·1–65·8), 17·4% (7·7–28·4), and 
59·5% (34·2–86·9) of units, respectively, recorded 
decreases in deaths from diarrhoea greater than 10%. 
Diarrhoeal mortality was estimated to have increased in 
only 112 (0·5%) units over this time, exclusively in 
Central African Republic, Indonesia, Kenya, South 
Sudan, and Tunisia. Although massive imbalances in 
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Figure 4: Geographical inequality of childhood diarrhoeal mortality at the 
second administrative-level unit
The left panel shows the range of relative deviation from the country mean 
diarrhoea mortality rate for each country in 2000 (upper bar) and 2017 (lower bar, 
coloured by GBD super-region). Each bar represents the range from the lowest to 
highest second administrative-level unit deviation for each country. The right 
panel shows LMICs with at least one death from diarrhoea per 10 000 children at 
the second administrative-level unit ranked by childhood diarrhoea mortality rate 
in 2017. Mean mortality rates are shown as dark grey dots and are national-level 
aggregations that correspond to the results shown in figure 3. Each bar represents 
the range from the lowest to highest second administrative-level unit childhood 
diarrhoeal mortality rate for each country in 2000 (upper bar) and 2017 (lower 
bar, coloured by GBD super-region). Country names in both panels are the 
designated ISO 3166-1 alpha-3 codes. GBD=Global Burden of Diseases, Injuries, 
and Risk Factors Study. LMICs=low-income and middle-income countries.
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mortality rates within Africa persisted in 2017, most 
diarrhoeal deaths in LMICs occurred outside of Africa. 
Importantly, because of the juxtaposition of mortality 
rate to population size, the five units with the largest 
number of diarrhoeal deaths were all outside of Africa, 
specifically in Punjab, Pakistan (Dera Ghazi Khan, 
Faisalabad, Gujranwala, Lahore, and Multan; figure 2D). 
By comparison, the total number of deaths in these five 
units was more than double the total estimated diarrhoeal 
deaths in Liberia, Rwanda, and Togo.
Geographical inequality in diarrhoeal mortality
Within analyses of geographical inequality, focusing on 
maximum deviations from the country mean can mask 
subnational variation in space and time. Two exemplars 
of this masking are Indonesia (where units with the 
greatest deviation changed over time) and Peru (where 
the shape of the distribution of inequality changed even 
though the maximum deviation remained mostly stable; 
figure 3). In 2000, the units within Indonesia farthest 
from the mean were all within the first administrative-
level units (provinces) of modern-day Gorontalo, Nusa 
Tenggara Barat, Sulawesi Barat, and Sulawesi Tengah, 
with the largest relative deviation in the East Lombok 
Regency in Nusa Tenggara Barat (101·4% the national 
mortality rate; figures 3A, 4). By 2017, units in Papua 
were almost four times the Indonesian national average 
(figures 3B, 4). Units in Papua went from not ranking in 
the 60 units with the highest deviation in Indonesia 
in 2000 to having the 29 units with the highest deviations 
from the country average in 2017.
In Peru, several units had substantial deviations from 
the national average in 2000. The maximum relative 
geographical inequality occurred in Requena province, 
Loreto, with 0·80 (95% UI 0·65–0·97) deaths per 1000, 
versus a country mortality rate of 0·4 (0·4–0·5) deaths 
per 1000 children, a relative deviation of 83·7%. Since 
2000, Peru has seen substantial reductions in diarrhoeal 
mortality, and yet, in 2017, mortality in Requena province, 
Loreto, was 56·8% higher than the country average. 
Although the maximum relative deviation increased 
over this period, the distribution of inequality shows a 
different pattern. In 2000, 58 of 196 provinces in Peru 
had mortality rates at least 20% higher than the country 
average (figure 3C); however, in 2017, only 34 provinces 
had mortality rates at least 20% higher than the country 
average (figure 3D).
Drivers of geographical inequality in diarrhoeal mortality
A risk factor can drive the risk of diarrhoeal mortality by 
increasing the chance that either a child is infected, 
infection develops into a disease episode, or an episode 
results in death. Both CGF and WASH risk factors were 
used as covariates in the diarrhoea prevalence model 
because they are predictive of infections that lead to 
diarrhoea.7,22 Conversely, ORS coverage was not used 
because there is clinical evidence that ORS prevents 
mortality from diarrhoea,11,12 but there is no evidence that 
it affects diarrhoea prevalence or incidence. Because of 
the possibility for circularity, post-hoc correlative analyses 
between the subnational variation in diarrhoeal mortality 
and the subnational variation in CGF and WASH must 
be interpreted carefully. However, consistent with the 
logic of previous risk factor analysis,3 excluding these 
known drivers of diarrhoea incidence would diminish the 
fit and usefulness of the output more than the potential 
loss of interpretation due to circularity. It is important 
to note that by using both stacked generalisation and 
the Gaussian process, which incorporates estimates of 
spatial and temporal autocorrelation, diarrhoeal mortality 
patterns are not a simple direct function of the risk factors 
used. Most importantly, the counterfactual analysis is 
based on externally derived risk ratios for each level of 
each risk factor.
To assess drivers of the temporal trends in diarrhoeal 
mortality, we did a counterfactual analysis by comparing 
the estimated number of diarrhoeal deaths in 2017 to the 
scenario in which these risk factors had been at their 
2000 levels. For the primary counterfactual analysis, 
we did not include ORS because only a few studies 
have quantified ORS efficacy precisely and, thus, there 
is no universally accepted risk ratio for its efficacy. 
A counter factual analysis that includes ORS is presented 
2000
2017
2000 and 2017
Location of lower 20%
A
(Figure 6 continues on next page)
Articles
www.thelancet.com   Published online May 6, 2020   https://doi.org/10.1016/S0140-6736(20)30114-8 11
in appendix 1 (pp 61–62). Additional factors that affect 
death rates and counts, such as changes in population 
structure and size and sociodemographic factors, were 
kept at their 2017 levels. Reductions in CGF averted 
245 000 deaths, and 46 000 deaths were averted by 
improvements in WASH (figure 5D). In units where one 
or both risk factor groups improved from 2000 to 2017, 
we estimated 297 000 deaths were averted because of 
combined changes in WASH and CGF risk factors 
(figure 5B). The largest attributable relative reductions 
in diarrhoeal mortality in units where at least one child 
was estimated to have died from diarrhoea in 2017 were 
seen in India, Myanmar, Rwanda, and Somalia, where 
gains were mainly attributable to concurrent reductions 
in CGF (figures 5A, C). Conversely, the largest absolute 
attributable reductions in diarrhoeal mortality were in 
Ethiopia, India, Niger, and Pakistan. In Lahore, within 
the Punjab province of Pakistan, these gains were almost 
entirely due to improvements in WASH, whereas in the 
units within Ethiopia, India, and Niger, the averted 
deaths were almost entirely due to reductions in CGF 
(figures 5B, D). Although many regions that saw deaths 
averted because of WASH also had improvements 
associated with CGF, there were regions in Angola 
and Pakistan where the reduction in diarrhoea-related 
mortality was mainly driven by WASH (figure 5C). 
In 2000, across all LMIC units, 68·0–99·2% of childhood 
diarrhoeal deaths were attributable to either CGF or 
WASH risk factors. In 2017, the range increased slightly 
to 60·1–99·0% (appendix 1 pp 61–62).
Compared with other modelled regions, much of sub-
Saharan Africa had a disproportionally high burden of 
diarrhoeal disease. Inequality, as measured by the Gini 
coefficient across units within sub-Saharan Africa, 
remained mostly constant in sub-Saharan Africa from 
2000 (0·30) to 2017 (0·33). We identified units with child 
populations at highest risk of death due to diarrhoea, 
defined as units with 20% of the population in Africa 
living in areas with the highest mortality rates (figure 6A). 
No combination of risk factors that drove high diarrhoeal 
mortality was discernible; however, units had at least 
one risk factor at a high level (figures 6B–D). Of 565 units 
accounting for 20% of children with the highest 
diarrhoeal mortality risk in 2017, 447 were also among 
Figure 6: Second administrative-level units in sub-Saharan Africa with 
childhood mortality rates in the lower 20%
Second administrative units are coloured according to where children are most 
likely to die of diarrhoea, or the lower 20% (A). Scatter plots of mortality rates 
against ORS coverage (B),21 access to improved sanitation (C), and childhood 
stunting prevalence (D). The left axes are based on 2000 values whereas the 
right axes are based on 2017 values. The scale change in the y axis is due to 
substantial decline in mortality rates across most of sub-Saharan Africa. 
Because lower 20% is itself a relative distinction, scales are adjusted accordingly. 
Maps reflect administrative boundaries, land cover, lakes, and population; 
grey-coloured grid cells were classified as barren or sparsely vegetated and had 
fewer than ten people per 1 × 1 km grid cell, or were not included in these 
analyses.33–38 ORS=oral rehydration solution.
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those with the highest risk in 2000. The other 118 units 
that became relatively worse from 2000 to 2017 were 
predominantly in South Sudan (n=45), Central African 
Republic (n=39), and Madagascar (n=21). In units in 
South Sudan, although ORS decreased slightly on 
average (2·7%), there was a notable decline in average 
prevalence of childhood stunting across the 45 units 
(9·6%; figure 6D). As with high-burden areas in 2017, the 
risk factors that correlated with improvements from 
2000 to 2017 were varied. For example, of the 295 units 
that transitioned out of the lower 20% from 2000 to 2017, 
53 came from Liberia. In these units, surprisingly, both 
ORS coverage and access to improved sanitation declined 
on average from 2000 to 2017 (average ORS coverage 
declined by 14·1% and average access to improved 
sanitation declined by 11·7%; figures 6B, C). Conversely, 
and more consistent with the improvements in these 
units of Liberia, childhood stunting consistently improved 
from 2000 to 2017 (childhood stunting decreases ranged 
from 14·4% to 25·4%; figure 6D).
Discussion
Over the past 18 years, substantial reductions have been 
noted in diarrhoeal mortality, but these improvements 
have not been recorded uniformly across LMICs. 
Although only 112 (0·5%) of 24 143 units had increases in 
mortality rates from 2000 to 2017, 5729 (24%) units saw an 
increase in incidence of childhood diarrhoea over this 
period. While some units with high diarrhoeal burden in 
2000 have subsequently noted impressive reductions, 
other units with historically high diarrhoeal burden have 
seen some of the most meagre improvements. Globally, 
most of the diarrhoeal burden is in sub-Saharan Africa 
and south Asia, but we recorded substantial variation 
within countries in these subcontinents. Moreover, 
even in regions with relatively low diarrhoeal burden, we 
identified units that far exceeded their respective country’s 
averages. Our estimates identified the units of each 
country where diarrhoeal burden was disproportionally 
high, pinpointing the locations most in need of targeted 
interventions.
Identifying a country’s worst-performing units also 
leads to awareness of the extent of geographical 
inequality, measured by the range of relative deviation 
from the mean. It likewise pinpoints if these units are 
left behind consistently over time. In Peru, some metrics 
of geographical inequality seem to be mostly consistent 
from 2000 to 2017. However, deeper analysis into the 
distribution of burden across the country showed that 
more than half of its worst-performing units substantially 
improved relative to others in the country. Only a few 
Peruvian units east of the Andes seem to be left behind. 
Conversely, in Indonesia, the worst-performing units in 
2000 actually improved more than average, whereas 
units in Papua became substantially worse relative to the 
rest of the country, leading to units exceeding the country 
average by almost 350%.
The different subnational patterns that emerge between 
relative and absolute deviations are echoed when 
comparing units with the highest mortality rates versus 
those units where most children die from diarrhoea. 
Across all LMICs, even though units with the highest 
mortality risk were all in sub-Saharan Africa, the five units 
where most children died were all in Pakistan. These same 
patterns hold within many countries. In the Democratic 
Republic of the Congo, most deaths from diarrhoea 
occurred in the capital city of Kinshasa, where the death 
rate was 1·5 (95% UI 1·3–1·9) deaths per 1000 children; 
however, the second administrative-level unit with the 
highest death rate (Kazumba, Kasaï; 2·0 [1·6–2·4] deaths 
per 1000 children) had an estimated 307 (251–368) 
childhood deaths in 2017 because of its small population 
size (figure 2). When attempting to further reduce 
diarrhoeal burden in a country or region, interventionists, 
policy makers, and other stakeholders must consider and 
balance the needs of both locations with the highest risk 
and locations with the highest burden.
Changes in diarrhoeal burden are due to myriad related 
drivers, but findings of a study3 showed that CGF and poor 
access to improved WASH were most associated with 
global reductions in the burden of diarrhoea. Although 
there are other important risk factors for diarrhoea 
(eg, poor rotavirus vaccine coverage), we did a counter-
factual CGF and WASH risk factor analysis. Using newly 
available subnational estimates, we have provided a deeper 
understanding of the drivers of past success and location-
specific needs to prevent future deaths. Large portions of 
sub-Saharan Africa have seen improvements because of 
reductions in CGF. Likewise, reductions in diarrhoeal 
deaths in Ethiopia have coincided with improvements 
in access to better sanitation. We identified second 
administrative-level units of Ethiopia, India, Niger, and 
Pakistan where reductions in CGF and WASH risk factors 
since 2000 have averted more than 1000 childhood deaths 
due to diarrhoea. Some of the regions that have seen the 
slowest improvements can also be linked to risk factors. In 
much of Pakistan, for example, small improve ments in 
WASH have been overwhelmed by increases in CGF 
(figure 5). Although it is unlikely that risk factors will be 
eliminated completely, and thus counting all deaths still 
attributable to a risk factor is slightly misleading, we did 
identify patterns relating disproportionately high values 
of risk factors with dis pro portionally high burden. In 
sub-Saharan Africa, no combination of risk factors was 
found that needed reduction across the region; rather, in 
different locations of high burden, a different suite of risk 
factors seemed to be associated with the high risk of death 
due to diarrhoea (figure 6).
In the future, our analysis could aid in targeting of site-
specific interventions, for example, to units of India, 
Indonesia, and Nigeria that did worse than their respective 
country average and had higher than country-average 
levels of childhood stunting. Although nationwide cam-
paigns to reduce childhood stunting have a role in averting 
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further unnecessary deaths, focused interventions in 
the worst-performing units might reduce the recorded 
substantial geographical inequality in diarrhoeal burden. 
Our results did not always indicate that every unit needing 
improvements required reductions in all risk factors, even 
within one country. As an example, although most poorly 
performing units within Nigeria had lower than average 
access to improved sanitation and ORS coverage, almost 
10% of children in poorly performing units lived in 
locations estimated to have better than average sanitation 
and ORS coverage. Careful consideration of location-
specific risk factors is necessary to optimally design 
intervention programmes.
Limitations associated with our analysis include 
inherent biases in survey data, which are associated with 
data obtained with recall biases. There is also uneven data 
coverage in space and time, in particular from zones of 
conflict and political instability (eg, Afghanistan, Iraq, 
Pakistan, Syria, and Yemen). Regarding the geospatial 
modelling framework, our approach is designed to 
optimise out-of-sample predictive validity and, as such, it 
is difficult to do inferential analyses. Our spatial and 
temporal autocorrelation assumptions might smooth 
over focal epidemics. Additionally, our model does not 
distinguish differences in rates of disease or death by 
causes of diarrhoea because we are currently unable to 
fully model all causes of diarrhoea. For this study, we 
assume that the case-fatality rate is constant for any 
particular year within any particular country. This 
assumption is unlikely, but since it is more likely that the 
places with higher than average prevalence are likely to be 
the same places with a higher than average case-fatality 
rate, our observations about subnational inequality in 
diarrhoea mortality probably underestimate these quan-
tities. As previously mentioned, the risk factor analyses 
must be interpreted with care. CGF and WASH risk 
factors are used as covariates within the diarrhoea model, 
so it is unsurprising that the final diarrhoeal burden 
estimates correlate with those covariates. On the other 
hand, because of both the spatiotemporal smoothing that 
occurs through the Gaussian process and the stacked 
generalisation beforehand, it is not necessary for the final 
output to correspond with the covariates used in the 
regression. Although ORS was not used in the prevalence 
model, many of the base covariates used in diarrhoea 
(eg, elevation or population density) were used in the ORS 
model.
Our counterfactual analysis assumed that each risk 
factor affects diarrhoeal mortality and changes through 
time independently of all other risk factors. Accurately 
capturing and quantifying the covariation of these risk 
factors in space and time would further improve the use 
of that analysis. Our study also does not address the 
protective effect of breastfeeding with potential for the 
reduction of diarrhoeal burden.39 Breastfeeding can 
account for some of the lower rates of reduction in 
diarrhoea incidence and would be useful to investigate 
in future studies. Diarrhoea is a common symptom 
triggered by different causes and, to further focus 
preventive health-care strategies, a more in-depth 
analysis of diarrhoea causes should be done in future 
studies. Finally, despite the availability of vaccines to 
rotavirus, which is the leading cause of diarrhoea, we did 
not include coverage of this vaccine in our risk factor 
analysis because subnational estimates of rotavirus 
vaccine coverage are not yet available for all LMICs.
Because geospatial information is available for some 
causes of diarrhoea, estimating the subnational variation 
in those pathogens would help the interpretations and 
recommendations resultant from this work. Our current 
modelling framework aggregates ages to all children 
younger than 5 years but, in view of the strong relation 
between the case-fatality ratio and age, an age-specific 
model would be more informative. Our current frame-
work prioritises prediction over inference. There is an 
increased need in building inferential models that can be 
used to infer the effect of interventions. Finally, our 
model assumes that every child within a population is 
equally likely to become infected and, on infection, is 
equally likely to develop disease or die. It does not 
address the vicious cycle of repeated enteric infections 
in the same individual that causes more severe symp-
toms. Incorporating these dynamics into our modelling 
framework can improve accurate accounting of the long-
term burden of diarrhoea and quantification of those 
who are most vulnerable.
Every year, more than half a million children in LMICs 
die from diarrhoea; however, with treatment, most of 
these deaths can be averted. Our results serve as a 
new tool to pinpoint where these deaths occur. By 
establishment of good health practices from birth, 
children can be protected from enteric infections 
resulting in serious diarrhoeal episodes. Finally, by 
ensuring access to healthy environments, exposure to 
enteric pathogens can be prevented. Optimising 
reduction of diarrhoeal burden can be achieved by 
focusing on locations with the highest risk or those with 
the highest burden; either way, a detailed understanding 
of diarrhoeal morbidity and mortality, in addition to risk 
factors that drive diarrhoea, is necessary at the spatial 
scale at which policy is implemented. This work provides 
the data necessary to formulate effective policies and 
precision public health programmes to ultimately stop 
the preventable loss of so many young lives.
Local Burden of Disease Diarrhoea Collaborators
Robert C Reiner Jr, Kirsten E Wiens, Aniruddha Deshpande, 
Mathew M Baumann, Paulina A Lindstedt, Brigette F Blacker, 
Christopher E Troeger, Lucas Earl, Sandra B Munro, Degu Abate, 
Hedayat Abbastabar, Foad Abd-Allah, Ahmed Abdelalim, 
Ibrahim Abdollahpour, Rizwan Suliankatchi Abdulkader, Getaneh Abebe, 
Kedir Hussein Abegaz, Lucas Guimarães Abreu, Michael R M Abrigo, 
Manfred Mario Kokou Accrombessi, Dilaram Acharya, Maryam Adabi, 
Oladimeji M Adebayo, Rufus Adesoji Adedoyin, Victor Adekanmbi, 
Olatunji O Adetokunboh, Davoud Adham, Beyene Meressa Adhena, 
Mohsen Afarideh, Keivan Ahmadi, Mehdi Ahmadi, Anwar E Ahmed, 
Muktar Beshir Ahmed, Rushdia Ahmed, Olufemi Ajumobi, 
Articles
14 www.thelancet.com   Published online May 6, 2020   https://doi.org/10.1016/S0140-6736(20)30114-8
Chalachew Genet Akal, Temesgen Yihunie Akalu, Ali S Akanda, 
Genet Melak Alamene, Turki M Alanzi, James R Albright, 
Jacqueline Elizabeth Alcalde Rabanal, Birhan Tamene Alemnew, 
Zewdie Aderaw Alemu, Beriwan Abdulqadir Ali, Muhammad Ali, 
Mehran Alijanzadeh, Vahid Alipour, Syed Mohamed Aljunid, Ali Almasi, 
Amir Almasi-Hashiani, Hesham M Al-Mekhlafi, Khalid Altirkawi, 
Nelson Alvis-Guzman, Nelson J Alvis-Zakzuk, Azmeraw T Amare, 
Saeed Amini, Arianna Maever Loreche Amit, Catalina Liliana Andrei, 
Masresha Tessema Anegago, Mina Anjomshoa, Fereshteh Ansari, 
Carl Abelardo T Antonio, Ernoiz Antriyandarti, 
Seth Christopher Yaw Appiah, Jalal Arabloo, Olatunde Aremu, 
Bahram Armoon, Krishna K Aryal, Afsaneh Arzani, Mohsen Asadi-Lari, 
Alebachew Fasil Ashagre, Hagos Tasew Atalay, Suleman Atique, 
Sachin R Atre, Marcel Ausloos, Leticia Avila-Burgos, Ashish Awasthi, 
Nefsu Awoke, Beatriz Paulina Ayala Quintanilla, Getinet Ayano, 
Martin Amogre Ayanore, Asnakew Achaw Ayele, Yared Asmare Aynalem, 
Samad Azari, Ebrahim Babaee, Alaa Badawi, Shankar M Bakkannavar, 
Senthilkumar Balakrishnan, Ayele Geleto Bali, Maciej Banach, 
Aleksandra Barac, Till Winfried Bärnighausen, Huda Basaleem, 
Quique Bassat, Mohsen Bayati, Neeraj Bedi, Masoud Behzadifar, 
Meysam Behzadifar, Yibeltal Alemu Bekele, Michelle L Bell, 
Derrick A Bennett, Dessalegn Ajema Berbada, Tina Beyranvand, 
Anusha Ganapati Bhat, Krittika Bhattacharyya, Suraj Bhattarai, 
Soumyadeep Bhaumik, Ali Bijani, Boris Bikbov, Raaj Kishore Biswas, 
Kassawmar Angaw Bogale, Somayeh Bohlouli, Oliver J Brady, 
Nicola Luigi Bragazzi, Andrey Nikolaevich Briko, 
Nikolay Ivanovich Briko, Sharath Burugina Nagaraja, Zahid A Butt, 
Ismael R Campos-Nonato, Julio Cesar Campuzano Rincon, 
Rosario Cárdenas, Félix Carvalho, Franz Castro, Collins Chansa, 
Pranab Chatterjee, Vijay Kumar Chattu, Bal Govind Chauhan, 
Ken Lee Chin, Devasahayam J Christopher, Dinh-Toi Chu, 
Rafael M Claro, Natalie M Cormier, Vera M Costa, Giovanni Damiani, 
Farah Daoud, Lalit Dandona, Rakhi Dandona, Amira Hamed Darwish, 
Ahmad Daryani, Jai K Das, Rajat Das Gupta, Tamirat Tesfaye Dasa, 
Claudio Alberto Davila, Nicole Davis Weaver, Dragos Virgil Davitoiu, 
Jan-Walter De Neve, Feleke Mekonnen Demeke, 
Asmamaw Bizuneh Demis, Gebre Teklemariam Demoz, 
Edgar Denova-Gutiérrez, Kebede Deribe, Assefa Desalew, 
Getenet Ayalew Dessie, Samath Dhamminda Dharmaratne, 
Preeti Dhillon, Meghnath Dhimal, Govinda Prasad Dhungana, 
Daniel Diaz, Eric L Ding, Helen Derara Diro, Shirin Djalalinia, 
Huyen Phuc Do, David Teye Doku, Christiane Dolecek, Manisha Dubey, 
Eleonora Dubljanin, Bereket Duko Adema, Susanna J Dunachie, 
Andre R Durães, Senbagam Duraisamy, Andem Effiong, Aziz Eftekhari, 
Iman El Sayed, Maysaa El Sayed Zaki, Maha El Tantawi, 
Demelash Abewa Elemineh, Shaimaa I El-Jaafary, Hajer Elkout, 
Aisha Elsharkawy, Shymaa Enany, Aklilu Endalamaw, 
Daniel Adane Endalew, Sharareh Eskandarieh, Alireza Esteghamati, 
Arash Etemadi, Tamer H Farag, Emerito Jose A Faraon, 
Mohammad Fareed, Roghiyeh Faridnia, Andrea Farioli, Andre Faro, 
Hossein Farzam, Ali Akbar Fazaeli, Mehdi Fazlzadeh, Netsanet Fentahun, 
Seyed-Mohammad Fereshtehnejad, Eduarda Fernandes, Irina Filip, 
Florian Fischer, Masoud Foroutan, Joel Msafiri Francis, 
Richard Charles Franklin, Joseph Jon Frostad, Takeshi Fukumoto, 
Reta Tsegaye Gayesa, Kidane Tadesse Gebremariam, 
Ketema Bizuwork Gebremedhin, Gebreamlak Gebremedhn Gebremeskel, 
Getnet Azeze Gedefaw, Yilma Chisha Dea Geramo, Birhanu Geta, 
Kebede Embaye Gezae, Ahmad Ghashghaee, Fariba Ghassemi, 
Paramjit Singh Gill, Ibrahim Abdelmageed Ginawi, Srinivas Goli, 
Nelson G M Gomes, Sameer Vali Gopalani, Bárbara Niegia Garcia Goulart, 
Ayman Grada, Harish Chander Gugnani, Davide Guido, 
Rafael Alves Guimarães, Yuming Guo, Rahul Gupta, Rajeev Gupta, 
Nima Hafezi-Nejad, Michael Tamene Haile, Gessessew Bugssa Hailu, 
Arvin Haj-Mirzaian, Arya Haj-Mirzaian, Brian James Hall, 
Demelash Woldeyohannes Handiso, Hamidreza Haririan, 
Ninuk Hariyani, Ahmed I Hasaballah, Md. Mehedi Hasan, 
Amir Hasanzadeh, Hadi Hassankhani, Hamid Yimam Hassen, 
Desta Haftu Hayelom, Behnam Heidari, Nathaniel J Henry, 
Claudiu Herteliu, Fatemeh Heydarpour, Hagos D de Hidru, 
Chi Linh Hoang, Praveen Hoogar, Mojtaba Hoseini-Ghahfarokhi, 
Naznin Hossain, Mostafa Hosseini, Mehdi Hosseinzadeh, 
Mowafa Househ, Guoqing Hu, Ayesha Humayun, Syed Ather Hussain, 
Segun Emmanuel Ibitoye, Olayinka Stephen Ilesanmi, Milena D Ilic, 
Leeberk Raja Inbaraj, Seyed Sina Naghibi Irvani, 
Sheikh Mohammed Shariful Islam, Chinwe Juliana Iwu, Anelisa Jaca, 
Nader Jafari Balalami, Nader Jahanmehr, Mihajlo Jakovljevic, Amir Jalali, 
Achala Upendra Jayatilleke, Ensiyeh Jenabi, Ravi Prakash Jha, 
Vivekanand Jha, John S Ji, Peng Jia, Kimberly B Johnson, Jost B Jonas, 
Jacek Jerzy Jóźwiak, Ali Kabir, Zubair Kabir, Amaha Kahsay, 
Hamed Kalani, Tanuj Kanchan, Behzad Karami Matin, André Karch, 
Surendra Karki, Amir Kasaeian, Gebremicheal Gebreslassie Kasahun, 
Gbenga A Kayode, Ali Kazemi Karyani, Peter Njenga Keiyoro, 
Daniel Bekele Ketema, Yousef Saleh Khader, Morteza Abdullatif Khafaie, 
Nauman Khalid, Ali Talha Khalil, Ibrahim Khalil, Rovshan Khalilov, 
Md Nuruzzaman Khan, Ejaz Ahmad Khan, Gulfaraz Khan, Junaid Khan, 
Khaled Khatab, Amir Khater, Mona M Khater, Alireza Khatony, 
Maryam Khayamzadeh, Mohammad Khazaei, Salman Khazaei, 
Ehsan Khodamoradi, Mohammad Hossein Khosravi, 
Jagdish Khubchandani, Aliasghar A Kiadaliri, Yun Jin Kim, 
Ruth W Kimokoti, Adnan Kisa, Sezer Kisa, Niranjan Kissoon, 
Shivakumar K M Kondlahalli, Margaret N Kosek, Ai Koyanagi, 
Moritz U G Kraemer, Kewal Krishan, Nuworza Kugbey, G Anil Kumar, 
Manasi Kumar, Pushpendra Kumar, Dian Kusuma, Carlo La Vecchia, 
Ben Lacey, Aparna Lal, Dharmesh Kumar Lal, Faris Hasan Lami, 
Van C Lansingh, Savita Lasrado, Paul H Lee, Mostafa Leili, 
Tsegaye Lolaso Lenjebo, Aubrey J Levine, Sonia Lewycka, Shanshan Li, 
Shai Linn, Rakesh Lodha, Joshua Longbottom, Platon D Lopukhov, 
Sameh Magdeldin, Phetole Walter Mahasha, Narayan Bahadur Mahotra, 
Deborah Carvalho Malta, Abdullah A Mamun, Farzad Manafi, 
Navid Manafi, Ana-Laura Manda, Mohammad Ali Mansournia, 
Chabila Christopher Mapoma, Dadi Marami, Laurie B Marczak, 
Francisco Rogerlândio Martins-Melo, Winfried März, Anthony Masaka, 
Manu Raj Mathur, Pallab K Maulik, Benjamin K Mayala, 
Colm McAlinden, Man Mohan Mehndiratta, Ravi Mehrotra, 
Kala M Mehta, Gebrekiros Gebremichael Meles, Addisu Melese, 
Ziad A Memish, Alemayehu Toma Mena, Ritesh G Menezes, 
Melkamu Merid Mengesha, Desalegn Tadese Mengistu, 
Getnet Mengistu, Tuomo J Meretoja, Bartosz Miazgowski, 
Kebadnew Mulatu M Mihretie, Molly K Miller-Petrie, Edward J Mills, 
Seyed Mostafa Mir, Parvaneh Mirabi, Erkin M Mirrakhimov, 
Amjad Mohamadi-Bolbanabad, Dara K Mohammad, 
Karzan Abdulmuhsin Mohammad, Yousef Mohammad, 
Aso Mohammad Darwesh, Naser Mohammad Gholi Mezerji, 
Noushin Mohammadifard, Ammas Siraj Mohammed, 
Jemal Abdu Mohammed, Shafiu Mohammed, Farnam Mohebi, 
Ali H Mokdad, Yoshan Moodley, Ghobad Moradi, Masoud Moradi, 
Mohammad Moradi-Joo, Maziar Moradi-Lakeh, Paula Moraga, 
Abbas Mosapour, Simin Mouodi, Seyyed Meysam Mousavi, 
Miliva Mozaffor, Atalay Goshu Muluneh, Moses K Muriithi, 
Christopher J L Murray, GVS Murthy, Kamarul Imran Musa, 
Ghulam Mustafa, Saravanan Muthupandian, Mehdi Naderi, 
Ahamarshan Jayaraman Nagarajan, Mohsen Naghavi, Farid Najafi, 
Vinay Nangia, Javad Nazari, Duduzile Edith Ndwandwe, Ionut Negoi, 
Josephine W Ngunjiri, Cuong Tat Nguyen, QuynhAnh P Nguyen, 
Trang Huyen Nguyen, Dabere Nigatu, Dina Nur Anggraini Ningrum, 
Chukwudi A Nnaji, Marzieh Nojomi, Jean Jacques Noubiap, 
In-Hwan Oh, Oluchi Okpala, Andrew T Olagunju, Ahmed Omar Bali, 
Obinna E Onwujekwe, Doris D V Ortega-Altamirano, 
Osayomwanbo Osarenotor, Frank B Osei, Mayowa Ojo Owolabi, 
Mahesh P A, Jagadish Rao Padubidri, Adrian Pana, Tahereh Pashaei, 
Sanghamitra Pati, Ajay Patle, George C Patton, Kebreab Paulos, 
Veincent Christian Filipino Pepito, Alexandre Pereira, Norberto Perico, 
Konrad Pesudovs, David M Pigott, Bakhtiar Piroozi, James A Platts-Mills, 
Mario Poljak, Maarten J Postma, Hadi Pourjafar, Farshad Pourmalek, 
Akram Pourshams, Hossein Poustchi, Sergio I Prada, Liliana Preotescu, 
Hedley Quintana, Mohammad Rabiee, Navid Rabiee, Amir Radfar, 
Alireza Rafiei, Fakher Rahim, Vafa Rahimi-Movaghar, 
Muhammad Aziz Rahman, Fatemeh Rajati, Kiana Ramezanzadeh, 
Saleem M Rana, Chhabi Lal Ranabhat, Davide Rasella, 
David Laith Rawaf, Salman Rawaf, Lal Rawal, Giuseppe Remuzzi, 
Vishnu Renjith, Andre M N Renzaho, Melese Abate Reta, Satar Rezaei, 
Ana Isabel Ribeiro, Jennifer Rickard, Carlos Miguel Rios González, 
Articles
www.thelancet.com   Published online May 6, 2020   https://doi.org/10.1016/S0140-6736(20)30114-8 15
Maria Jesus Rios-Blancas, Leonardo Roever, Luca Ronfani, 
Elias Merdassa Roro, Ali Rostami, Dietrich Rothenbacher, 
Enrico Rubagotti, Salvatore Rubino, Anas M Saad, Siamak Sabour, 
Ehsan Sadeghi, Saeed Safari, Mahdi Safdarian, Rajesh Sagar, 
Mohammad Ali Sahraian, S Mohammad Sajadi, 
Mohammad Reza Salahshoor, Nasir Salam, Farkhonde Salehi, 
Saleh Salehi Zahabi, Hosni Salem, Marwa R Rashad Salem, Yahya Salimi, 
Hamideh Salimzadeh, Evanson Zondani Sambala, Abdallah M Samy, 
Juan Sanabria, Itamar S Santos, Sivan Yegnanarayana Iyer Saraswathy, 
Abdur Razzaque Sarker, Benn Sartorius, Brijesh Sathian, 
Maheswar Satpathy, Alyssa N Sbarra, Lauren E Schaeffer, 
David C Schwebel, Anbissa Muleta Senbeta, Subramanian 
Senthilkumaran, Hosein Shabaninejad, Amira A Shaheen, 
Masood Ali Shaikh, Ali S Shalash, Seifadin Ahmed Shallo, 
Mehran Shams-Beyranvand, MohammadBagher Shamsi, 
Morteza Shamsizadeh, Mehdi Sharif, Muki Shehu Shey, Kenji Shibuya, 
Wondimeneh Shibabaw Shiferaw, Mika Shigematsu, Apurba Shil, 
Jae Il Shin, Rahman Shiri, Reza Shirkoohi, Si Si, Soraya Siabani, 
Jasvinder A Singh, Narinder Pal Singh, Dhirendra Narain Sinha, 
Malede Mequanent Sisay, Eirini Skiadaresi, David L Smith, 
Mohammad Reza Sobhiyeh, Anton Sokhan, Moslem Soofi, 
Joan B Soriano, Muluken Bekele Sorrie, Ireneous N Soyiri, 
Chandrashekhar T Sreeramareddy, Agus Sudaryanto, 
Mu’awiyyah Babale Sufiyan, Hafiz Ansar Rasul Suleria, Bryan L Sykes, 
Koku Sisay Tamirat, Aberash Abay Tassew, Nuno Taveira, Bineyam Taye, 
Arash Tehrani-Banihashemi, Mohamad-Hani Temsah, 
Berhe Etsay Tesfay, Fisaha Haile Tesfay, Zemenu Tadesse Tessema, 
Kavumpurathu Raman Thankappan, Sathish Thirunavukkarasu, 
Nihal Thomas, Kenean Getaneh Tlaye, Boikhutso Tlou, 
Marcos Roberto Tovani-Palone, Eugenio Traini, Khanh Bao Tran, 
Indang Trihandini, Irfan Ullah, Bhaskaran Unnikrishnan, 
Sahel Valadan Tahbaz, Pascual R Valdez, Santosh Varughese, 
Yousef Veisani, Francesco S Violante, Sebastian Vollmer, Theo Vos, 
Fiseha Wadilo Wada, Yasir Waheed, Yafeng Wang, Yuan-Pang Wang, 
Girmay Teklay Weldesamuel, Catherine A Welgan, Ronny Westerman, 
Taweewat Wiangkham, Tissa Wijeratne, Charles Shey Wiysonge, 
Haileab Fekadu Wolde, Dawit Zewdu Wondafrash, 
Tewodros Eshete Wonde, Ai-Min Wu, Gelin Xu, Ali Yadollahpour, 
Seyed Hossein Yahyazadeh Jabbari, Tomohide Yamada, Mehdi Yaseri, 
Muluken Azage Yenesew, Alex Yeshaneh, Mekdes Tigistu Yilma, 
Ebrahim M Yimer, Paul Yip, Biruck Desalegn Yirsaw, Engida Yisma, 
Naohiro Yonemoto, Mustafa Z Younis, Hebat-Allah Salah A Yousof, 
Chuanhua Yu, Hasan Yusefzadeh, Mohammad Zamani, 
Carlos Zambrana-Torrelio, Hamed Zandian, Ayalew Jejaw Zeleke, 
Nejimu Biza Zepro, Taye Abuhay Zewale, Dongyu Zhang, 
Yunquan Zhang, Xiu-Ju Zhao, Arash Ziapour, Sanjay Zodpey, and 
Simon I Hay.
Affiliations
Institute for Health Metrics and Evaluation (R C Reiner Jr PhD, 
K E Wiens PhD, A Deshpande MPH, M M Baumann BS, 
P A Lindstedt MPH, B Blacker MPH, C E Troeger MPH, L Earl, 
S B Munro PhD, J R Albright BS, N M Cormier MPSA, F Daoud BS, 
Prof L Dandona MD, Prof R Dandona PhD, N Davis Weaver MPH, 
S D Dharmaratne MD, T Farag PhD, J J Frostad MPH, N J Henry BS, 
K B Johnson MS, A J Levine MSPH, L B Marczak PhD, B K Mayala PhD, 
M K Miller-Petrie MSc, Prof A H Mokdad PhD, Prof C J L Murray DPhil, 
Prof M Naghavi MD, Q P Nguyen BS, D M Pigott DPhil, 
A N Sbarra MPH, L E Schaeffer MS, Prof D L Smith PhD, 
Prof T Vos PhD, C A Welgan BS, Prof S I Hay FMedSci), Department of 
Global Health (I Khalil MD), Department of Health Metrics Sciences, 
School of Medicine (R C Reiner Jr PhD, Prof L Dandona, 
Prof A H Mokdad PhD, Prof C J L Murray DPhil, Prof M Naghavi MD, 
D M Pigott DPhil, Prof B Sartorius PhD, Prof D L Smith PhD, 
Prof T Vos PhD, Prof S I Hay FMedSci), University of Washington, 
Seattle, WA, USA; College of Health and Medical Sciences 
(H D Diro BS), Department of Epidemiology and Biostatistics 
(M Mengesha MPH), Department of Medical Laboratory Sciences 
(D Abate MSc, S Balakrishnan PhD, D Marami MSc), School of Nursing 
and Midwifery (T T Dasa MSc, A Desalew MS), School of Pharmacy 
(A S Mohammed BA, G Mengistu MS), School of Public Health 
(A G Bali MPH), Haramaya University, Harar, Ethiopia 
(G A Gedefaw MS); Advanced Diagnostic and Interventional Radiology 
Research Center (H Abbastabar PhD), Cancer Biology Research Center 
(R Shirkoohi PhD), Cancer Research Institute (R Shirkoohi PhD), 
Department of Economics and Management Sciences for Health 
(M Moradi-Joo MS), Department of Environmental Health Engineering 
(M Fazlzadeh PhD), Department of Epidemiology and Biostatistics 
(M Hosseini PhD, M Mansournia PhD, M Yaseri PhD), Department of 
Health Management and Economics (S Mousavi PhD), Department of 
Microbiology (A Hasanzadeh PhD), Department of Pharmacology 
(A Haj-Mirzaian MD, A Haj-Mirzaian MD), Digestive Diseases Research 
Institute (Prof A Pourshams MD, H Poustchi PhD, H Salimzadeh PhD), 
Endocrinology and Metabolism Research Center (M Afarideh MD, 
Prof A Esteghamati MD, B Heidari MD), Hematology-Oncology and 
Stem Cell Transplantation Research Center (A Kasaeian PhD), Iran 
National Institute of Health Research (F Mohebi MD), Metabolomics 
and Genomics Research Center (F Rahim PhD), Multiple Sclerosis 
Research Center (S Eskandarieh PhD, Prof M Sahraian MD), 
Non-communicable Diseases Research Center (F Mohebi MD), 
Ophthalmology Department (F Ghassemi MD), School of Medicine 
(N Hafezi-Nejad MD), Sina Trauma and Surgery Research Center 
(Prof V Rahimi-Movaghar MD, M Safdarian MD), Tehran University of 
Medical Sciences, Tehran, Iran (A Etemadi PhD); Department of Medical 
Parasitology (M M Khater MD), Department of Neurology 
(Prof F Abd-Allah MD, Prof A Abdelalim MD, S I El-Jaafary MD), 
Endemic Medicine and Hepatogastroentrology Department 
(A Elsharkawy MD), Medical Parasitology Department, Faculty of 
Medicine (H S A Yousof MD), Public Health and Community Medicine 
Department (M R R Salem MD), Urology Department 
(Prof H Salem MD), Cairo University, Cairo, Egypt; Cardiovascular 
Research Institute (N Mohammadifard PhD), Neuroscience Research 
Center (I Abdollahpour PhD), Isfahan University of Medical Sciences, 
Isfahan, Iran; Department of Public Health (R S Abdulkader MD), 
Research Department Prince Mohammed Bin Abdulaziz Hospital 
(Prof Z A Memish MD), Ministry of Health, Riyadh, Saudi Arabia; 
Department of Epidemiology and Biostatistics (K A Bogale MPH, 
K M Mihretie MPH, T A Zewale MS), Department of Medical Laboratory 
Sciences (G A Abebe MSc, C G Akal MS, F M Demeke MS, 
A Melese MSc), Department of Public Health Nutrition 
(N Fentahun PhD), Department of Reproductive Health and Population 
Studies (Y A Bekele MPH, D Nigatu MPH), School of Public Health 
(M A Yenesew PhD), Bahir Dar University, Bahir Dar, Ethiopia 
(A T Amare PhD, G A Gedefaw MS); Biostatistics and Health 
Informatics (K H Abegaz MPH), Public Health Department 
(D Handiso MPH), School of Health Sciences (G M Alamene BS), 
Madda Walabu University, Bale Robe, Ethiopia; Department of Microbial 
Cellular and Molecular Biology (F W Wada MS), Department of 
Microbiology, Immunology and Parasitology (B T Alemnew MS), 
Department of Nursing and Midwifery (K B Gebremedhin MSc), 
Department of Pharmacology (D Z Wondafrash MS), Department of 
Public Health (E M Roro MPH), Radiotherapy Center 
(K H Abegaz MPH), School of Allied Health Sciences (E Yisma MPH), 
School of Public Health (K Deribe PhD), Addis Ababa University, Addis 
Ababa, Ethiopia (B T Alemnew MS, G T Demoz MPharm); Department 
of Maternal and Child Nursing and Public Health (Prof D C Malta PhD), 
Department of Pediatric Dentistry (Prof L G Abreu PhD), Nutrition 
Department (Prof R M Claro PhD), Federal University of Minas Gerais, 
Belo Horizonte, Brazil; Research Department (M R M Abrigo PhD), 
Philippine Institute for Development Studies, Quezon City, Philippines; 
Bénin Clinical Research Institute (IRCB), Cotonou, Benin 
(M M K Accrombessi PhD); Department of Preventive Medicine 
(D Acharya MPH), Dongguk University, Gyeongju, South Korea; 
Department of Community Medicine (D Acharya MPH), Kathmandu 
University, Devdaha, Nepal; Autism Spectrum Disorders Research 
Center (E Jenabi PhD), Chronic Diseases (Home Care) Research Center 
(M Shamsizadeh MSc), Department of Biostatistics 
(N Mohammad Gholi Mezerji MSc), Department of Environmental 
Health Engineering (M Khazaei PhD, M Leili PhD), Department of 
Epidemiology (S Khazaei PhD), Social Determinants of Health Research 
Center (A Fazaeli PhD), Hamadan University of Medical Sciences, 
Hamadan, Iran (M Adabi PhD); Department of Medicine 
(O M Adebayo MD), University College Hospital, Ibadan, Nigeria; 
Articles
16 www.thelancet.com   Published online May 6, 2020   https://doi.org/10.1016/S0140-6736(20)30114-8
Department of Medical Rehabilitation (Prof R A Adedoyin PhD), 
Obafemi Awolowo University, Ile-Ife, Nigeria; School of Medicine 
(V Adekanmbi PhD), Cardiff University, Cardiff, UK; Centre for 
Evidence Based Health Care (A Jaca PhD), Department of Global Health 
(O O Adetokunboh MD, O Okpala PhD), Health Systems and Public 
Health (C J Iwu MS), Stellenbosch University, South Africa; Cochrane 
South Africa (C J Iwu MS, A Jaca PhD, P W Mahasha PhD, 
C A Nnaji MPH, D E Ndwandwe PhD, E Z Sambala PhD, 
Prof C S Wiysonge MD), South African Medical Research Council, 
Cape Town, South Africa; Department of Community Medicine 
(H Zandian PhD), Department of Environmental Health Engineering 
(M Fazlzadeh PhD), School of Health (D Adham PhD), Social 
Determinants of Health Research Center (H Zandian PhD), Ardabil 
University of Medical Science, Ardabil, Iran; Biomedical Sciences 
Division (G B Hailu MSc), Department of Biostatistics (K Gezae MSc), 
Department of Microbiology and Immunology (S Muthupandian PhD), 
Department of Nursing (G Gebremeskel MSc), Department of Nutrition 
and Dietetics (A Kahsay MPH), Department of Pharmacology and 
Toxicology (D Z Wondafrash MS), Department of Public Health 
(G G Meles), School of Medicine (D T Mengistu MSc), School of 
Pharmacy (E M Yimer MSc), School of Public Health 
(B M Adhena MPH, K T Gebremariam MS, N B Zepro MS), Mekelle 
University, Mekelle, Ethiopia (F H Tesfay MPH); Environmental 
Technologies Research Center (M Ahmadi PhD), Medical Physics 
Department (A Yadollahpour PhD), Social Determinants of Health 
Research Center (M A Khafaie PhD), Thalassemia and 
Hemoglobinopathy Research Center (F Rahim PhD), Ahvaz Jundishapur 
University of Medical Sciences, Ahvaz, Iran; Lincoln Medical School 
(K Ahmadi PhD), Universities of Nottingham & Lincoln, Lincoln, UK; 
Faculty of Economics and Rural Development (A E Ahmed PhD), 
University of Gezira, Wad Madani, Sudan; Department of Epidemiology 
(M B Ahmed MPH), School of Nursing (A B Demis MS), Jimma 
University, Jimma, Ethiopia; James P Grant School of Public Health 
(R Ahmed MPH, R Das Gupta MPH), BRAC University, Dhaka, 
Bangladesh; Health Systems and Population Studies Division 
(R Ahmed MPH), International Centre for Diarrhoeal Disease Research, 
Bangladesh, Dhaka, Bangladesh; School of Community Health Sciences 
(O Ajumobi MPH), University of Nevada Reno, Reno, NV, USA; 
National Malaria Elimination Program (O Ajumobi MPH), Federal 
Ministry of Health, Abuja, Nigeria; Department of Clinical Chemistry 
(A F Ashagre MS), Department of Epidemiology and Biostatistics 
(T Y Akalu MPH, A G Muluneh MPH, M M Sisay MPH, 
K S Tamirat MPH, Z T Tessema MS, H F Wolde MPH), Department of 
Medical Parasitology (A J Zeleke MS), Institute of Public Health 
(A A Tassew MPH), University of Gondar, Gondar, Ethiopia 
(A A Ayele MSc, A Endalamaw MSc); Department of Civil and 
Environmental Engineering (A S Akanda PhD), University of Rhode 
Island, Kingston, RI, USA; Department of Health Information 
Management and Technology (T M Alanzi PhD), Forensic Medicine 
Division (Prof R G Menezes MD), Imam Abdulrahman Bin Faisal 
University, Dammam, Saudi Arabia; Center for Health Systems 
Research (L Avila-Burgos PhD, D D V Ortega-Altamirano DrPH, 
M Rios-Blancas MPH), Center for Nutrition and Health Research 
(E Denova-Gutiérrez DSc), Centre of Health System 
(J E Alcalde Rabanal PhD), National Institute of Public Health, 
Cuernavaca, Mexico (I R Campos-Nonato PhD, 
J Campuzano Rincon PhD); College of Health Sciences 
(B T Alemnew MS), Department of Medical Laboratory Science 
(M A Reta MS), Department of Nursing (A B Demis MS, K G Tlaye MS), 
Woldia University, Woldia, Ethiopia; Department of Nursing 
(G A Dessie MSc), Department of Public Health (D B Ketema MPH, 
T E Wonde MPH), Department of Statistics (D A Elemineh MS), 
Debre Markos University, Debre Markos, Ethiopia (Z A Alemu MPH); 
Medical Technical Institute (B A Ali PhD), Erbil Polytechnic University, 
Erbil, Iraq; Faculty of Pharmacy (B A Ali PhD), Ishik University, Erbil, 
Iraq; Department of Biotechnology (M Ali PhD), Quaid-i-Azam 
University Islamabad, Islamabad, Pakistan; Social Determinants of 
Health Research Center (M Alijanzadeh PhD), Qazvin University of 
Medical Sciences, Qazvin, Iran; Department of Community and Family 
Medicine (Prof M Nojomi MD, A Tehrani-Banihashemi PhD), 
Department of Epidemiology (M Asadi-Lari PhD), Department of Health 
Policy (H Shabaninejad PhD), Department of Health Services 
Management (A Ghashghaee BSc), Department of Neuroscience 
(M Safdarian MD), Department of Neurosurgery (M Khosravi MD), 
Health Economics Department (V Alipour PhD), Health Management 
and Economics Research Center (V Alipour PhD, J Arabloo PhD, 
S Azari PhD), Minimally Invasive Surgery Research Center 
(A Kabir MD), Ophthalmology Department (N Manafi MD), Pars 
Advanced and Minimally Invasive Medical Manners Research Center 
(A Kasaeian PhD), Preventive Medicine and Public Health Research 
Center (E Babaee PhD, M Moradi-Lakeh MD, Prof M Nojomi MD, 
A Tehrani-Banihashemi PhD), Iran University of Medical Sciences, 
Tehran, Iran (T Beyranvand PhD); Department of Health Policy and 
Management (Prof S M Aljunid PhD), Kuwait University, Safat, Kuwait; 
International Centre for Casemix and Clinical Coding 
(Prof S M Aljunid PhD), National University of Malaysia, 
Bandar Tun Razak, Malaysia; Clinical Research Development Center 
(A Khatony PhD , M Naderi MS), Department of Anatomical Sciences 
(M R Salahshoor PhD), Department of Environmental Health 
Engineering (Prof A Almasi PhD), Department of Epidemiology & 
Biostatistics (Prof F Najafi PhD, Y Salimi PhD), Department of Health 
Education & Promotion (S Siabani PhD, A Ziapour PhD), Department of 
Psychiatry (A Jalali PhD), Department of Public Health 
(A Kazemi Karyani PhD), Department of Radiology and Nuclear 
Medicine (M Hoseini-Ghahfarokhi PhD, E Khodamoradi PhD, 
S Salehi Zahabi PhD), Department of Sports Medicine & Rehabilitation 
(M Shamsi PhD), Department of Vascular & Endovascular Surgery 
(M Sobhiyeh MD), Medical Biology Research Center 
(F Heydarpour PhD), Research Center for Environmental Determinants 
of Health (Prof B Karami Matin PhD, A Kazemi Karyani PhD, 
M Moradi PhD, F Rajati PhD, S Rezaei PhD, Prof E Sadeghi PhD), 
Social Development and Health Promotion Research Center 
(A Khatony PhD, Y Salimi PhD, M Soofi PhD), Taleghani Hospital 
(F Salehi MA), Kermanshah University of Medical Sciences, 
Kermanshah, Iran (H Farzam MD, M Moradi PhD, M Sobhiyeh MD); 
Department of Epidemiology (A Almasi-Hashiani PhD), Department of 
Pediatrics (J Nazari PhD), Health Services Management Department 
(S Amini PhD), Arak University of Medical Sciences, Arak, Iran; Medical 
Research Center (H M Al-Mekhlafi PhD), Jazan University, Jazan, 
Saudi Arabia (Prof N Bedi MD); Department of Medical Parasitology 
(H M Al-Mekhlafi PhD), Sana’a University, Sana’a, Yemen; Department 
of Pediatrics (M Temsah MD), Internal Medicine Department 
(Y Mohammad MD), King Saud University, Riyadh, Saudi Arabia 
(K Altirkawi MD); Research Group in Health Economics 
(Prof N Alvis-Guzman PhD), University of Cartagena, Cartagena, 
Colombia; Research Group in Hospital Management and Health Policies 
(Prof N Alvis-Guzman PhD), University of the Coast, Barranquilla, 
Colombia; Departamento de Ciencias Económicas 
(N J Alvis-Zakzuk MS), Universidad de la Costa, Barranquilla, Colombia; 
Observatorio Nacional de Salud (N J Alvis-Zakzuk MS), National 
Institute of Health, Bogotá, D.C., Colombia; Sansom Institute 
(A T Amare PhD), South Australian Health and Medical Research 
Institute, Adelaide, SA, Australia; Department of Epidemiology and 
Biostatistics (A L Amit BS), Department of Health Policy and 
Administration (C A T Antonio MD, E A Faraon MD), Medical 
Informatics Unit (E A Faraon MD), University of the Philippines Manila, 
Manila, Philippines; Center for Clinical Global Health Education 
(S R Atre PhD), Department of International Health (M N Kosek MD), 
Department of Radiology and Radiological Sciences (N Hafezi-Nejad MD, 
A Haj-Mirzaian MD), Online Programs for Applied Learning 
(A L Amit BS), Johns Hopkins University, Baltimore, MD, USA; 
Department of Infectious Diseases (L Preotescu PhD), Department of 
General Surgery (D V Davitoiu PhD, I Negoi PhD), Carol Davila 
University of Medicine and Pharmacy, Bucharest, Romania 
(C Andrei PhD); Division of Human Nutrition and Health 
(M T Anegago PharmD), Wageningen University & Research, 
Wageningen, Netherlands; Nutrition & Food Science Research 
Directorate (M T Anegago PharmD), Ethiopian Public Health Institute, 
Addis Ababab, Ethiopia; Social Determinants of Health Research Center 
(M Anjomshoa PhD), Rafsanjan University of Medical Sciences, 
Rafsanjan, Iran; Department of Pharmacology and Toxicology 
(A Eftekhari PhD), Research Center for Evidence Based Medicine- Health 
Articles
www.thelancet.com   Published online May 6, 2020   https://doi.org/10.1016/S0140-6736(20)30114-8 17
Management and Safety Promotion Research Institute (F Ansari PhD), 
School of Nursing and Midwifery (H Hassankhani PhD), Tabriz 
University of Medical Sciences, Tabriz, Iran (H Haririan PhD); 
Ravi Vaccine and Serum Research Institute (F Ansari PhD), Agricultural 
Research, Education and Extension Organization (AREEO), Tehran, 
Iran; Department of Applied Social Sciences (C A T Antonio MD), 
School of Nursing (P H Lee PhD), Hong Kong Polytechnic University, 
Hong Kong, China; Agribusiness Study Program (E Antriyandarti PhD), 
Universitas Sebelas Maret, Surakarta, Indonesia; Department of 
Sociology and Social Work (S Appiah Mphil), Kwame Nkrumah 
University of Science and Technology, Kumasi, Ghana; Center for 
International Health (S Appiah Mphil), Ludwig Maximilians University, 
Munich, Germany; School of Health Sciences (O Aremu PhD), 
Birmingham City University, Birmingham, UK; School of Nursing and 
Midwifery (B Armoon PhD), Social Determinants of Health Research 
Center (B Armoon PhD), Saveh University of Medical Sciences, Saveh, 
Iran; Monitoring Evaluation and Operational Research Project 
(K K Aryal PhD), Abt Associates Nepal, Lalitpur, Nepal; Department of 
Clinical Biochemistry (S Mir MSc , A Mosapour PhD), Fatemeh Zahra 
Infertility and Reproductive Health Center (P Mirabi PhD), Infectious 
Diseases and Tropical Medicine Research Center (A Rostami PhD), 
Nursing and Midwifery School (A Arzani DrPH), Social Determinants of 
Health Research Center (A Bijani PhD), Student Research Committee 
(M Zamani MD), Babol University of Medical Sciences, Babol, 
Iran (A Arzani DrPH, S Mouodi MD); Development of Research and 
Technology Center (S Djalalinia PhD), International Relations 
Department (M Asadi-Lari PhD), Ministry of Health and Medical 
Education, Tehran, Iran; Department of Nursing (H T Atalay MS, 
G Gebremeskel MSc, G T Weldesamuel MS), School of Pharmacy 
(G T Demoz MPharm, G G Kasahun MS), Aksum University, Aksum, 
Ethiopia; Department of Family and Community Medicine 
(Prof I A Ginawi MD), Department of Health Informatics 
(S Atique PhD), University of Ha’il, Ha’il, Saudi Arabia; Dr D Y Patil 
Medical College (S R Atre PhD), Dr D Y Patil University, Pune, India; 
School of Business (Prof M Ausloos PhD), University of Leicester, 
Leicester, UK; Department of Statistics and Econometrics 
(Prof M Ausloos PhD, Prof C Herteliu PhD, A Pana MD), Bucharest 
University of Economic Studies, Bucharest, Romania; Indian Institute of 
Public Health (A Awasthi PhD, Prof S Zodpey PhD), Indian Institute of 
Public Health, Gurugram, India (D K Lal MD, M R Mathur PhD); 
Department of Medicine (F W Wada MS), Department of Midwifery 
(K Paulos MS), Department of Nursing (N Awoke MS), School of Public 
Health (T L Lenjebo MPH), Wolaita Sodo University, Wolaita Sodo, 
Ethiopia; The Judith Lumley Centre (B Ayala Quintanilla PhD), La Trobe 
University, Melbourne, VIC, Australia; General Office for Research and 
Technological Transfer (B Ayala Quintanilla PhD), Peruvian National 
Institute of Health, Lima, Peru; School of Public Health (G Ayano MS), 
Curtin University, Perth, WA, Australia (B Duko Adema MPH); 
Department of Family and Community Health (N Kugbey PhD), 
Department of Health Policy Planning and Management 
(M A Ayanore PhD), University of Health and Allied Sciences, Ho, 
Ghana; School of Health (A A Ayele MSc), University of New England, 
Armidale, NSW, Australia; Department of Nursing (Y A Aynalem MSc, 
W S Shiferaw MS), Debre Berhan University, Debre Berhan, Ethiopia; 
Public Health Risk Sciences Division (A Badawi PhD), Public Health 
Agency of Canada, Toronto, ON, Canada; Department of Medicine 
(V Chattu MD), Department of Nutritional Sciences (A Badawi PhD), 
Joint Centre for Bioethics (F Manafi MD), University of Toronto, 
Toronto, ON, Canada; Department of Forensic Medicine 
(S M Bakkannavar MD, J Padubidri MD), Transdisciplinary Centre for 
Qualitative Methods (P Hoogar PhD), Manipal Academy of Higher 
Education, Manipal, India; Department of Hypertension 
(Prof M Banach PhD), Medical University of Lodz, Lodz, Poland; 
Polish Mothers’ Memorial Hospital Research Institute, Lodz, Poland 
(Prof M Banach PhD); Clinic for Infectious and Tropical Diseases 
(A Barac PhD), Clinical Center of Serbia, Belgrade, Serbia; Faculty of 
Medicine (A Barac PhD, E Dubljanin PhD), University of Belgrade, 
Belgrade, Serbia; Department of Ophthalmology (Prof J B Jonas MD), 
Heidelberg Institute of Global Health (HIGH) 
(Prof T W Bärnighausen MD, C Chansa MPH, Prof J De Neve MD, 
S Mohammed PhD), Medical Clinic V (Nephrology, Hypertensiology, 
Endocrinology, Diabetology, Rheumatology) (Prof W März MD), 
Heidelberg University, Heidelberg, Germany; Department of Genetics 
(A Pereira PhD), Department of Global Health and Population 
(Prof S Vollmer PhD), Department of Nutrition (E L Ding DSc), Medical 
School (M U G Kraemer PhD), T.H. Chan School of Public Health 
(Prof T W Bärnighausen MD), Harvard University, Boston, MA, USA; 
University of Aden, Aden, Yemen (H Basaleem PhD); Barcelona 
Institute for Global Health (Prof Q Bassat MD), University of Barcelona, 
Barcelona, Spain; Catalan Institution for Research and Advanced Studies 
(ICREA), Barcelona, Spain (Prof Q Bassat MD, A Koyanagi MD); Health 
Human Resources Research Center (M Bayati PhD), Shiraz University 
of Medical Sciences, Shiraz, Iran; Department of Community Medicine 
(Prof N Bedi MD), Gandhi Medical College Bhopal, Bhopal, India; 
Department of Epidemiology and Biostatistics (M Behzadifar MSc), 
Social Determinants of Health Research Center (M Behzadifar PhD), 
Lorestan University of Medical Sciences, Khorramabad, Iran; School of 
Forestry and Environmental Studies (Prof M L Bell PhD), Yale 
University, New Haven, CT, USA; Centre for Tropical Medicine and 
Global Health (C Dolecek MD, S J Dunachie PhD, S Lewycka PhD), 
Department of Zoology (M U G Kraemer PhD), Nuffield Department of 
Population Health (D A Bennett PhD, B Lacey DPhil), University of 
Oxford, Oxford, UK (Prof V Jha MD); Department of Public Health 
(D A Berbada MPH, Y C D Geramo MS, D H Hayelom MPH, 
M B Sorrie MPH), Arba Minch University, Arba Minch, Ethiopia; 
Internal Medicine (A G Bhat MD), University of Massachusetts Medical 
School, Springfield, MA, USA; Department of Statistical and 
Computational Genomics (K Bhattacharyya MSc), National Institute of 
Biomedical Genomics, Kalyani, India; Department of Statistics 
(K Bhattacharyya MSc), University of Calcutta, Kolkata, India; 
Department of Global Health (S Bhattarai MD), Global Institute for 
Interdisciplinary Studies, Nepal; Research Department 
(P K Maulik PhD), The George Institute for Global Health, New Delhi, 
India (S Bhaumik MBBS, Prof V Jha MD); Istituto di Ricerche 
Farmacologiche Mario Negri IRCCS, Ranica, Italy (B Bikbov MD, 
N Perico MD, Prof G Remuzzi MD); School of Medicine 
(P K Maulik PhD), School of Optometry and Vision Science 
(Prof K Pesudovs PhD), School of Public Health and Community 
Medicine (S Karki PhD), Transport and Road Safety (TARS) Research 
Center (R Biswas MS), University of New South Wales, Sydney, NSW, 
Australia; School of Health Sciences (R Biswas MS), Swinburne 
University of Technology, Melbourne, VIC, Australia; Department of 
Basic Sciences (Prof M Sharif PhD), Department of Computer 
Engineering (M Hosseinzadeh PhD), Department of Laboratory 
Sciences (Prof M Sharif PhD), Department of Microbiology 
(S Valadan Tahbaz PhD), Department of Veterinary Medicine 
(S Bohlouli PhD), Islamic Azad University, Kermanshah, Iran; 
Department of Infectious Disease Epidemiology (O J Brady PhD), 
Faculty of Infectious and Tropical Diseases (Prof B Sartorius PhD), 
London School of Hygiene & Tropical Medicine, London, UK; University 
of Genoa, Genoa, Italy (N L Bragazzi PhD); Department of Biomedical 
Technologies (A N Briko MSc), Bauman Moscow State Technical 
University, Moscow, Russia; Department of Epidemiology and Evidence 
Based Medicine (Prof N I Briko DSc, P D Lopukhov Cand Of Sci [Med]), 
I M Sechenov First Moscow State Medical University, Moscow, Russia; 
Department of Community Medicine (S Burugina Nagaraja MD), 
Employees’ State Insurance Model Hospital, Bangalore, India; School of 
Public Health and Health Systems (Z A Butt PhD), University of 
Waterloo, Waterloo, ON, Canada; Al Shifa School of Public Health 
(Z A Butt PhD), Al Shifa Trust Eye Hospital, Rawalpindi, Pakistan; 
School of Medicine (J Campuzano Rincon PhD), University of the Valley 
of Cuernavaca, Cuernavaca, Mexico; Department of Population and 
Health (Prof R Cárdenas DSc), Metropolitan Autonomous University, 
Mexico City, Mexico; Department of Chemistry (N G M Gomes PhD), 
EPIUnit - Public Health Institute University Porto (ISPUP) 
(A Ribeiro PhD), REQUIMTE/LAQV (Prof E Fernandes PhD), Research 
Unit on Applied Molecular Biosciences (UCIBIO) (Prof F Carvalho PhD, 
Prof V M Costa PharmD), University of Porto, Porto, Portugal; 
Gorgas Memorial Institute for Health Studies, Panama City, Panama 
(F Castro MD, H Quintana PhD); Health, Nutrition and Population 
Global Practice (C Chansa MPH), World Bank, Lusaka, Zambia; Division 
of Epidemiology (P Chatterjee MD), National Institute of Cholera and 
Articles
18 www.thelancet.com   Published online May 6, 2020   https://doi.org/10.1016/S0140-6736(20)30114-8
Enteric Diseases, Kolkata, India; Population Research Centre 
(B Chauhan MPhil), Gokhale Institute of Politics and Economics, Pune, 
India; Department of Mathematical Demography & Statistics 
(P Dhillon PhD), Department of Population Studies (A Patle MPH, 
J Khan MPhil), International Institute for Population Sciences, Mumbai, 
India (B Chauhan MPhil, S Goli PhD, P Kumar PhD); Department of 
Epidemiology and Preventive Medicine (K L Chin PhD), School of Public 
Health and Preventive Medicine (Prof Y Guo PhD, S Li PhD, S Si PhD), 
Monash University, Melbourne, VIC, Australia; Department of 
Endocrinology (N Thomas), Department of Pulmonary Medicine 
(Prof D J Christopher MD), Christian Medical College and Hospital 
(CMC), Vellore, India (Prof S Varughese MD); Faculty of Biology 
(D Chu PhD), Hanoi National University of Education, Hanoi, Vietnam; 
Department of Dermatology (G Damiani MD), Department of Nutrition 
and Preventive Medicine (Prof J Sanabria MD), Case Western Reserve 
University, Cleveland, OH, USA; Clinical Medicine and Community 
Health (Prof C La Vecchia MD), Department of Dermatology 
(G Damiani MD), University of Milan, Milan, Italy; Public Health 
Foundation of India, Gurugam, India (Prof L Dandona, Prof R Dandona, 
G A Kumar PhD); Indian Council of Medical Research, New Delhi, India 
(Prof L Dandona); Department of Pediatrics (A H Darwish MD), Tanta 
University, Tanta, Egypt; Department of Immunology 
(Prof A Rafiei PhD), Department of Medicial Parasitology 
(Prof R Faridnia PhD); Molecular and Cell Biology Research Center 
(Prof A Rafiei PhD), Toxoplasmosis Research Center 
(Prof A Daryani PhD), Mazandaran University of Medical Sciences, Sari, 
Iran; Division of Women and Child Health (J K Das MD), Aga Khan 
University, Karachi, Pakistan; Department of Epidemiology and 
Biostatistics, Arnold School of Public Health (R Das Gupta MPH), 
University of South Carolina, Columbia, SC, USA; Population and 
Development (C A Davila PhD), Facultad Latinoamericana de Ciencias 
Sociales Mexico, Mexico City, Mexico; Department of Surgery 
(D V Davitoiu PhD), Clinical Emergency Hospital Sf. Pantelimon, 
Bucharest, Romania; Department of Global Health and Infection 
(K Deribe PhD), Brighton and Sussex Medical School, Brighton, UK; 
Department of Community Medicine (S D Dharmaratne MD), 
University of Peradeniya, Peradeniya, Sri Lanka; Health Research 
Section (M Dhimal PhD), Nepal Health Research Council, Kathmandu, 
Nepal; Department of Microbiology (G P Dhungana MSc), Far Western 
University, Mahendranagar, Nepal; Center of Complexity Sciences 
(Prof D Diaz PhD), National Autonomous University of Mexico, 
Mexico City, Mexico; Facultad de Medicina Veterinaria y Zootecnia 
(Prof D Diaz PhD), Autonomous University of Sinaloa, Culiacan 
Rosales, Mexico; Center of Excellence in Behavioral Medicine 
(H P Do PhD, C L Hoang BMedSc, T H Nguyen BMedSc), 
Nguyen Tat Thanh University, Ho Chi Minh City, Vietnam; Department 
of Population Health (D T Doku PhD), University of Cape Coast, 
Cape Coast, Ghana; Faculty of Social Sciences, Health Sciences 
(D T Doku PhD), University of Tampere, Tampere, Finland; 
Mahidol-Oxford Tropical Medicine Research Unit (C Dolecek MD, 
S J Dunachie PhD), Mahidol University, Bangkok, Thailand; World Food 
Programme, New Delhi, India (M Dubey PhD); Public Health 
(B Duko Adema MPH), Hawassa University, Hawassa, Ethiopia; 
Institute of Public Health (Prof D Rasella PhD), School of Medicine 
(Prof A R Durães PhD), Federal University of Bahia, Salvador, Brazil; 
Medicina Interna (Prof A R Durães PhD), Escola Bahiana de Medicina e 
Saúde Pública, Salvador, Brazil; Department of Marine Biotechnology 
(S Duraisamy PhD), Bharathidasan University, Tiruchirappalli, India; 
Clinical Epidemiology and Biostatistics (A Effiong MB), Department of 
Public Health (M N Khan MSc), University of Newcastle, Newcastle, 
NSW, Australia; Department of Microbiology (A Hasanzadeh PhD), 
Department of Nutrition and Food Sciences (H Poujafar PhD), 
Department of Pharmacology and Toxicology (A Eftekhari PhD), 
Department of Public Health (H Pourjafar PhD), Maragheh University 
of Medical Sciences, Maragheh, Iran; Biomedical Informatics and 
Medical Statistics (I El Sayed PhD), Pediatric Dentistry and Dental 
Public Health Department (Prof M El Tantawi PhD), Alexandria 
University, Alexandria, Egypt; Department of Clinical Pathology 
(Prof M El Sayed Zaki PhD), Mansoura University, Mansoura, Egypt; 
Department of Community Medicine (H Elkout PhD), Tripoli University, 
Tripoli, Libya; World Health Organization (WHO), Tripoli, Libya 
(H Elkout PhD); Department of Microbiology and Immunology 
(S Enany PhD), Department of Physiology (Prof S Magdeldin PhD), 
Suez Canal University, Ismailia, Egypt; Department of Midwifery 
(D A Endalew MS), Wolkite University, Wolkite, Ethiopia 
(A Yeshaneh BHlthSci); Division of Cancer Epidemiology and Genetics 
(A Etemadi PhD), National Cancer Institute, Bethesda, MD, USA; 
College of Medicine (M Fareed PhD), Department of Pathology 
(N Salam PhD), Imam Muhammad Ibn Saud Islamic University, Riyadh, 
Saudi Arabia; Department of Medical and Surgical Sciences 
(A Farioli PhD, Prof F S Violante MD), University of Bologna, Bologna, 
Italy; Department of Psychology (Prof A Faro PhD), Federal University of 
Sergipe, São Cristóvão, Brazil; Department of Medicine 
(D K Mohammad PhD), Department of Neurobiology 
(S Fereshtehnejad PhD), Karolinska Institutet, Stockholm, Sweden; 
Division of Neurology (S Fereshtehnejad PhD), University of Ottawa, 
Ottawa, ON, Canada; Psychiatry Department (I Filip MD), Kaiser 
Permanente, Fontana, CA, USA; College of Graduate Health Sciences 
(A Radfar MD), School of Health Sciences (I Filip MD), AT Still 
University, Mesa, AZ, USA; Department of Population Medicine and 
Health Services Research (F Fischer PhD), Bielefeld University, 
Bielefeld, Germany; Abadan Faculty of Medical Sciences 
(M Foroutan PhD), Abadan School of Medical Sciences, Abadan, Iran; 
Department of Family Medicine and Primary Care (J M Francis PhD), 
University of the Witwatersrand, Johannesburg, South Africa; College of 
Public Health, Medical and Veterinary Science (R C Franklin PhD), 
James Cook University, Douglas, QLD, Australia; Department of 
Dermatology (T Fukumoto PhD), Kobe University, Kobe, Japan; 
Gene Expression & Regulation Program (T Fukumoto PhD), The Wistar 
Institute, Philadelphia, PA, USA; Department of Public Health 
(M T Yilma MPH), Nursing Department (R T Gayesa MS), Public Health 
Department (E M Roro MPH), Wollega University, Nekemte, Ethiopia; 
Department of Pharmacy (B Geta MS, G Mengistu MS), Wollo 
University, Dessie, Ethiopia; Unit of Academic Primary Care 
(Prof P S Gill DM), University of Warwick, Coventry, UK; Center for the 
Study of Regional Development (S Goli PhD), Jawahar Lal Nehru 
University, New Delhi, India; Department of Biostatistics and 
Epidemiology (S V Gopalani MPH), University of Oklahoma, Oklahoma 
City, OK, USA; Department of Health and Social Affairs 
(S V Gopalani MPH), Government of the Federated States of Micronesia, 
Palikir, Federated States of Micronesia; Postgraduate Program in 
Epidemiology (Prof B N G Goulart DSc), Federal University of 
Rio Grande do Sul, Porto Alegre, Brazil; Department of Dermatology 
(A Grada MD), Boston University, Boston, MA, USA; Department of 
Epidemiology (Prof H C Gugnani PhD), Department of Microbiology 
(Prof H C Gugnani PhD), Saint James School of Medicine, The Valley, 
Anguilla; Epidemiology Unit (D Guido PhD), Agency for Health 
Protection, Milano, Italy; Instituto de Patologia Tropical e Saúde Pública 
(R A Guimarães MS), Federal University of Goias, Goiânia, Brazil; 
Department of Epidemiology and Biostatistics (Prof Y Guo PhD), 
Zhengzhou University, Zhengzhou, China; March of Dimes, Arlington, 
VA, USA (Prof R Gupta MD); School of Public Health 
(Prof R Gupta MD), West Virginia University, Morgantown, WV, USA; 
Academics and Research Department (Prof R Gupta MD), Rajasthan 
University of Health Sciences, Jaipur, India; Department of Medicine 
(Prof R Gupta MD), Mahatma Gandhi University of Medical Sciences & 
Technology, Jaipur, India; Department of Nursing (M T Haile MS), 
St Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia; 
Cancer Research Center (M Khayamzadeh MD), Department of 
Epidemiology (S Sabour PhD), Department of Pharmacology 
(K Ramezanzadeh PharmD), Emergency Department (S Safari MD), 
Obesity Research Center (A Haj-Mirzaian MD), Ophthalmic Research 
Center (M Yaseri PhD), Research Institute for Endocrine Sciences 
(S N Irvani MD), Safety Promotion and Injury Prevention Research 
Center (N Jahanmehr PhD), School of Management and Medical 
Education (N Jahanmehr PhD), Shahid Beheshti University of Medical 
Sciences, Tehran, Iran; Global and Community Mental Health Research 
Group (B J Hall PhD), University of Macau, Macao, China; Department 
of Dental Public Health (N Hariyani PhD), Universitas Airlangga 
Indonesia, Surabaya, Indonesia; Australian Research Centre for 
Population Oral Health (N Hariyani PhD), University of Adelaide, 
Adelaide, SA, Australia; Department of Zoology (A I Hasaballah PhD), 
Articles
www.thelancet.com   Published online May 6, 2020   https://doi.org/10.1016/S0140-6736(20)30114-8 19
Al-Azhar University, Cairo, Egypt; Institute for Social Science Research 
(M Hasan MPH, A A Mamun PhD), The University of Queensland, 
Indooroopilly, QLD, Australia; Independent Consultant, Tabriz, Iran 
(H Hassankhani PhD); Department of Public Health 
(H Y Hassen MPH), Mizan-Tepi University, Teppi, Ethiopia; Unit of 
Epidemiology and Social Medicine (H Y Hassen MPH), University 
Hospital Antwerp, Wilrijk, Belgium; Department of Biostatistics and 
Epidemiology (H D de Hidru MPH), Department of Public Health 
(B E Tesfay MPH), Adigrat University, Adigrat, Ethiopia; Department of 
Pharmacology and Therapeutics (N Hossain MPH), Dhaka Medical 
College, Dhaka, Bangladesh; Department of Pharmacology 
(N Hossain MPH), Bangladesh Industrial Gases Limited, Tangail, 
Bangladesh; Computer Science Department (M Hosseinzadeh PhD), 
Department of Information Technology (A Mohammad Darwesh PhD), 
Diplomacy and Public Relations Department (A Omar Bali PhD), 
University of Human Development, Sulaymaniyah, Iraq; Division of 
Information and Computing Technology, College of Science and 
Engineering (Prof M Househ PhD), Hamad Bin Khalifa University, 
Doha, Qatar; Qatar Foundation for Education, Science, and Community 
Development, Doha, Qatar (Prof M Househ PhD); Department of 
Epidemiology and Health Statistics (Prof G Hu PhD), Central South 
University, Changsha, China; Department of Public Health and 
Community Medicine (Prof A Humayun PhD), Shaikh Khalifa Bin 
Zayed Al-Nahyan Medical and Dental College, Lahore, Pakistan; 
Dow Medical College (S A Hussain MD), Dow University of Health 
Sciences, Karachi, Pakistan; Department of Community Medicine 
(O S Ilesanmi PhD), Department of Health Promotion and 
Education(S E Ibitoye MPH), Institute for Advanced Medical Research 
and Training (Prof M O Owolabi DrM), University of Ibadan, Ibadan, 
Nigeria; Department of Epidemiology (Prof M D Ilic PhD), University of 
Kragujevac, Kragujevac, Serbia; Department of Family Medicine 
(L R Inbaraj MD), Bangalore Baptist Hospital, Bangalore, India; Institute 
for Physical Activity and Nutrition (S Islam PhD), National Centre for 
Farmer Health (M Rahman PhD), Deakin University, Burwood, VIC, 
Australia; Sydney Medical School (S Islam PhD), University of Sydney, 
Sydney, NSW, Australia; Department of Psychosis 
(N Jafari Balalami PhD), Babol Noshirvani University of Technology, 
Babol, Iran; Department for Health Care and Public Health 
(Prof M Jakovljevic PhD), Sechenov First Moscow State Medical 
University, Moscow, Russia; Faculty of Graduate Studies 
(A U Jayatilleke PhD), Institute of Medicine (A U Jayatilleke PhD), 
University of Colombo, Colombo, Sri Lanka; Department of Community 
Medicine (R P Jha MSc), Banaras Hindu University, Varanasi, India; 
Environmental Research Center (J S Ji DSc), Duke Kunshan University, 
Kunshan, China; Nicholas School of the Environment (J S Ji DSc), 
Duke University, Durham; Department of Earth Observation Science 
(P Jia PhD), Faculty of Geoinformation Science and Earth Observation 
(F B Osei PhD), University of Twente, Enschede, Netherlands; Beijing 
Ophthalmology & Visual Science Key (Prof J B Jonas MD), Beijing 
Tongren Hospital, Beijing, China; Department of Family Medicine and 
Public Health (J J Jóźwiak PhD), University of Opole, Opole, Poland; 
School of Public Health (Z Kabir PhD), University College Cork, Cork, 
UK; Infectious Diseases Research Center (H Kalani PhD), Golestan 
University of Medical Sciences, Gorgan, Iran (S Mir MSc); Department 
of Forensic Medicine and Toxicology (T Kanchan MD), Department of 
Paediatrics (Prof R Lodha MD), Department of Psychiatry 
(Prof R Sagar MD), All India Institute of Medical Sciences, Jodhpur, 
India; Institute for Epidemiology and Social Medicine (A Karch MD), 
University of Münster, Münster, Germany; Research and Development 
Team (S Karki PhD), Australian Red Cross Blood Service, Sydney, NSW, 
Australia; International Research Center of Excellence (G A Kayode PhD), 
Institute of Human Virology Nigeria, Abuja, Nigeria; Julius Centre for 
Health Sciences and Primary Care (G A Kayode PhD), Utrecht 
University, Utrecht, Netherlands; Department of Psychiatry 
(M Kumar PhD), Open, Distance and eLearning Campus 
(Prof P N Keiyoro PhD), School of Economics (M K Muriithi PhD), 
University of Nairobi, Nairobi, Kenya; Department of Public Health 
(Prof Y S Khader PhD), Jordan University of Science and Technology, 
Irbid, Jordan; School of Food and Agricultural Sciences (N Khalid PhD), 
University of Management and Technology, Lahore, Pakistan; 
Department of Biotechnology (A Khalil PhD), Qarshi University, Lahore, 
Pakistan; Department of Physiology (R Khalilov PhD), Baku State 
University, Baku, Azerbaijan; Epidemiology and Biostatistics 
Department (E A Khan MPH), Health Services Academy, Islamabad, 
Pakistan; Department of Medical Microbiology & Immunology 
(Prof G Khan PhD), United Arab Emirates University, Al Ain, 
United Arab Emirates; Department of Population Sciences 
(M N Khan MSc), Jatiya Kabi Kazi Nazrul Islam University, 
Mymensingh, Bangladesh; Faculty of Health and Wellbeing 
(K Khatab PhD), Sheffield Hallam University, Sheffield, UK, Sheffield, 
UK; College of Arts and Sciences (K Khatab PhD), Ohio University, 
Zanesville, OH, USA; Internal Medicine and Gastroenterology 
Department (A Khater MD), National Hepatology and Tropical Research 
Institute, Cairo, Egypt; Academy of Medical Science, Tehran, Iran 
(M Khayamzadeh MD); Department of Nutrition and Health Science 
(Prof J Khubchandani PhD), Ball State University, Muncie, IN, USA; 
Clinical Epidemiology Unit (A A Kiadaliri PhD), Lund University, Lund, 
Sweden; School of Medicine (Y Kim PhD), Xiamen University Malaysia, 
Sepang, Malaysia; Department of Nutrition (R W Kimokoti MD), 
Simmons University, Boston, MA, USA; School of Health Sciences 
(Prof A Kisa PhD), Kristiania University College, Oslo, Norway; 
Department of Nursing and Health Promotion (S Kisa PhD), Oslo 
Metropolitan University, Oslo, Norway; Department of Pediatrics 
(Prof N Kissoon MD), School of Population and Public Health 
(F Pourmalek PhD), University of British Columbia, Vancouver, BC, 
Canada; Public Health Dentistry, School of Dental Sciences 
(Prof S K M Kondlahalli MDS), Deemed University, Karad, India; 
Investigaciones Biomedicas (M N Kosek MD), Asociación Benéfica 
PRISMA, Iquitos, Peru; CIBERSAM (A Koyanagi MD), San Juan de Dios 
Sanitary Park, Sant Boi de Llobregat, Spain; Department of 
Anthropology (K Krishan PhD), Panjab University, Chandigarh, India; 
Department of Psychology and Health Promotion (N Kugbey PhD), 
Department of Public Health Medicine (Y Moodley PhD), Discipline of 
Public Health Medicine (B Tlou DrPH), University of KwaZulu-Natal, 
Durban, South Africa; Department of Epidemiology and Public Health 
(M R Mathur PhD), Division of Psychology and Language Sciences 
(M Kumar PhD), University College London, London, UK; Department 
of Primary Care and Public Health (Prof S Rawaf MD), Imperial College 
Business School (D Kusuma DSc), WHO Collaborating Centre for Public 
Health Education and Training (D L Rawaf MD), Imperial College 
London, London, UK; Faculty of Public Health (D Kusuma DSc, 
Prof I Trihandini PhD), University of Indonesia, Depok, Indonesia; 
National Institute for Health Research (NIHR) Oxford Biomedical 
Research Centre, Oxford, UK (B Lacey DPhil); National Centre for 
Epidemiology and Population Health (A Lal PhD), Australian National 
University, Canberra, ACT, Australia; Department of Community and 
Family Medicine (F H Lami PhD), University of Baghdad, Baghdad, 
Iraq; HelpMeSee, New York, NY, USA (Prof V C Lansingh PhD); 
International Relations (Prof V C Lansingh PhD), Mexican Institute of 
Ophthalmology, Queretaro, Mexico; Department of Otorhinolaryngology 
(ENT) (S Lasrado MS), Father Muller Medical College, Mangalore, India; 
Oxford University Clinical Research Unit (S Lewycka PhD), Wellcome 
Trust Asia Programme, Hanoi, Vietnam; School of Public Health 
(Prof S Linn DrPH), University of Haifa, Haifa, Israel; Department of 
Vector Biology (J Longbottom MS), Liverpool School of Tropical 
Medicine, Liverpool, UK; Proteomics and Metabolomics Unit 
(Prof S Magdeldin PhD), Children’s Cancer Hospital Egypt, Cairo, Egypt; 
Institute of Medicine (N B Mahotra MD), Tribhuvan University, 
Kathmandu, Nepal; Ophthalmology Department (N Manafi MD), 
University of Manitoba, Winnipeg, MB, Canada; Surgery Department 
(A Manda MD), Emergency University Hospital Bucharest, Bucharest, 
Romania; Department of Population Studies (C Mapoma PhD), 
University of Zambia, Lusaka, Zambia; Campus Caucaia 
(F R Martins-Melo PhD), Federal Institute of Education, Science and 
Technology of Ceará, Caucaia, Brazil; Clinical Institute of Medical and 
Chemical Laboratory Diagnostics (Prof W März MD), Medical University 
of Graz, Graz, Austria; Public Health Department (A Masaka MPH), 
Botho University-Botswana, Gaborone, Botswana; ICF International 
(B K Mayala PhD), ICF International, Rockville, MD, USA; Department 
of Ophthalmology (C McAlinden PhD, E Skiadaresi MD), Hywel Dda 
University Health Board, Carmarthen, UK; Neurology Department 
(Prof M Mehndiratta MD), Janakpuri Super Specialty Hospital Society, 
Articles
20 www.thelancet.com   Published online May 6, 2020   https://doi.org/10.1016/S0140-6736(20)30114-8
New Delhi, India; Department of Neurology (Prof M Mehndiratta MD), 
Govind Ballabh Institute of Medical Education and Research, New Dehli, 
India; Division of Preventive Oncology (Prof R Mehrotra PhD), National 
Institute of Cancer Prevention and Research, Noida, India; Department 
of Epidemiology and Biostatistics (K M Mehta DSc), University of 
California San Francisco, San Francisco, CA, USA; College of Medicine 
(Prof Z A Memish MD, M Temsah MD), Alfaisal University, Riyadh, 
Saudi Arabia; Department of Pharmacology (A T Mena PhD), 
ACS Medical College and Hospital, Hawassa, Ethiopia; Breast Surgery 
Unit (T J Meretoja MD), Helsinki University Hospital, Helsinki, Finland; 
University of Helsinki, Helsinki, Finland (T J Meretoja MD); Center for 
Innovation in Medical Education (B Miazgowski MD), Pomeranian 
Medical University, Szczecin, Poland (B Miazgowski MD); Department 
of Health Research Methods, Evidence and Impact (E J Mills PhD), 
Department of Psychiatry and Behavioural Neurosciences 
(A T Olagunju MD), McMaster University, Hamilton, ON, Canada; 
Faculty of Internal Medicine (Prof E M Mirrakhimov MD), Kyrgyz State 
Medical Academy, Bishkek, Kyrgyzstan; Department of Atherosclerosis 
and Coronary Heart Disease (Prof E M Mirrakhimov MD), National 
Center of Cardiology and Internal Disease, Bishkek, Kyrgyzstan; 
Department of Epidemiology and Biostatistics (G Moradi PhD), 
Environmental Health Research Center, Research Institute for Health 
Development (T Pashaei PhD), Social Determinants of Health Research 
Center (A Mohamadi-Bolbanabad PhD, G Moradi PhD, B Piroozi PhD), 
Kurdistan University of Medical Sciences, Sanandaj, Iran; Department 
of Food Technology (D K Mohammad PhD), Research Center 
(K A Mohammad PhD), Salahaddin University, Erbil, Iraq; Ishik 
University, Erbil, Iraq (K A Mohammad PhD); Department of Public 
Health (J A Mohammed MPH, N B Zepro MS), Samara University, 
Samara, Ethiopia; Department of Community Medicine 
(M B Sufiyan MD), Health Systems and Policy Research Unit 
(S Mohammed PhD), Ahmadu Bello University, Zaria, Nigeria; 
Department of Mathematical Sciences (P Moraga PhD), University of 
Bath, Bath, UK; Department of Clinical Biochemistry 
(A Mosapour PhD), Tarbiat Modares University, Tehran, Iran; 
Department of Biochemistry (M Mozaffor MD), Medical College for 
Women & Hospital, Dhaka, Bangladesh; Research Team 
(M Mozaffor MD), Biomedical Research Foundation, Dhaka, 
Bangladesh; School of Medical Sciences (K Musa PhD), Science 
University of Malaysia, Kubang Kerian, Malaysia; Indian Institute of 
Public Health (Prof G Murthy MD), Public Health Foundation of India, 
Hyderabad, India; Department of Pediatric Medicine 
(Prof G Mustafa MD), Nishtar Medical University, Multan, Pakistan; 
Department of Pediatrics & Pediatric Pulmonology 
(Prof G Mustafa MD), Institute of Mother & Child Care, Multan, 
Pakistan; Research and Analytics (A J Nagarajan MTech), Initiative for 
Financing Health and Human Development, Chennai, India; Research 
and Analytics (A J Nagarajan MTech), Bioinsilico Technologies, Chennai, 
India; Suraj Eye Institute, Nagpur, India (V Nangia MD); Iranian 
Ministry of Health and Medical Education, Tehran, Iran (J Nazari PhD); 
Emergency Hospital of Bucharest, Bucharest, Romania (I Negoi PhD); 
Department of Biological Sciences (J W Ngunjiri DrPH), University of 
Embu, Embu, Kenya; Institute for Global Health Innovations 
(C T Nguyen MPH), Duy Tan University, Hanoi, Vietnam; Public Health 
Department (D N A Ningrum MPH), Universitas Negeri Semarang, 
Kota Semarang, Indonesia; Graduate Institute of Biomedical Informatics 
(D N A Ningrum MPH), Taipei Medical University, Taipei City, Taiwan; 
Department of Medicine (J Noubiap MD, M S Shey PhD), Institute of 
Infectious Disease and Molecular Medicine (M S Shey PhD), School of 
Public Health and Family Medicine (C A Nnaji MPH, 
Prof C S Wiysonge MD), University of Cape Town, Cape Town, South 
Africa; Department of Preventive Medicine (I Oh PhD), Kyung Hee 
University, Dongdaemun-gu, South Korea; International Institute for 
Tropical Agriculture, Ibadan, Nigeria (O Okpala PhD); Department of 
Psychiatry (A T Olagunju MD), University of Lagos, Lagos, Nigeria; 
Department of Pharmacology and Therapeutics 
(Prof O E Onwujekwe PhD), University of Nigeria Nsukka, Enugu, 
Nigeria; Department of Environmental Management and Toxicology 
(O Osarenotor MS), University of Benin, Benin City, Nigeria; 
Department of Mathematics and Statistics (F B Osei PhD), University of 
Energy and Natural Resources, Sunyani, Ghana; Department of 
Respiratory Medicine (Prof M P A DNB), Jagadguru Sri 
Shivarathreeswara Academy of Health Education and Research, Mysore, 
India; Center for Health Outcomes & Evaluation, Bucharest, Romania 
(A Pana MD); Regional Medical Research Centre (S Pati MD), Indian 
Council of Medical Research, Bhubaneswar, India; International 
Institute of Health Management Research, New Delhi, India 
(A Patle MPH); Department of Agriculture and Food Systems 
(H Suleria PhD), Department of Medicine (Prof T Wijeratne MD), 
Department of Paediatrics (Prof G C Patton MD), Department of 
Psychology and Counselling (Prof T Wijeratne MD), University of 
Melbourne, Melbourne, VIC, Australia; Population Health Theme 
(Prof G C Patton MD), Murdoch Childrens Research Institute, 
Melbourne, VIC, Australia; Center for Research and Innovation 
(V F Pepito BS), Ateneo De Manila University, Pasig City, Philippines; 
Department of Internal Medicine (Prof I S Santos PhD), Department of 
Pathology and Legal Medicine (M R Tovani-Palone MSc), Department of 
Psychiatry (Y Wang PhD), Laboratory of Genetics and Molecular 
Cardiology (A Pereira PhD), University of São Paulo, Sao Paulo, Brazil; 
Division of Infectious Diseases and International Health 
(J A Platts-Mills MD), University of Virginia, Charlottesville, VA, USA; 
Institute of Microbiology and Immunology (Prof M Poljak PhD), 
University of Ljubljana, Ljubljana, Slovenia; Faculty of Economics and 
Business (Prof M J Postma PhD), University Medical Center Groningen 
(Prof M J Postma PhD), University of Groningen, Groningen, 
Netherlands; Fundación Valle del Lili, Cali, Colombia (S I Prada PhD); 
Infectious Diseases (L Preotescu PhD), National Institute of Infectious 
Diseases, Bucharest, Romania; Biomedical Engineering Department 
(Prof M Rabiee PhD), Amirkabir University of Technology, Tehran, Iran; 
Department of Chemistry (N Rabiee PhD), Sharif University of 
Technology, Tehran, Iran; College of Medicine (A Radfar MD), University 
of Central Florida, Orlando, FL, USA; School of Nursing and Healthcare 
Professions (M Rahman PhD), Federation University, Heidelberg, VIC, 
Australia; University Institute of Public Health (Prof S M Rana PhD), 
University of Lahore, Lahore, Pakistan; Public Health Department 
(Prof S M Rana PhD), University of Health Sciences, Lahore, Pakistan; 
Policy Research Institute, Kathmandu, Nepal (C L Ranabhat PhD); 
College of Medicine (Prof J Shin MD), Institute for Poverty Alleviation 
and International Development (C L Ranabhat PhD), Yonsei University, 
Wonju, South Korea; Gonçalo Moniz Institute (Prof D Rasella PhD), 
Oswaldo Cruz Foundation, Salvador, Brazil; University College London 
Hospitals, London, UK (D L Rawaf MD); Academic Public Health 
Department (Prof S Rawaf MD), Public Health England, London, UK; 
School of Health, Medical and Applied Sciences (L Rawal PhD), 
CQ University, Sydney, NSW, Australia; Neurology Department 
(V Renjith PhD), Sree Chitra Tirunal Institute for Medical Sciences and 
Technology, Thiruvananthapuram, India; School of Social Sciences and 
Psychology (Prof A M N Renzaho PhD), Translational Health Research 
Institute (Prof A M N Renzaho PhD), Western Sydney University, 
Penrith, NSW, Australia; Medical Microbiology (M A Reta MS), 
University of Pretoria, Pretoria, South Africa; Surgery Department 
(J Rickard MD), University of Minnesota, Minneapolis, MN, USA; 
Surgery Department (J Rickard MD), University Teaching Hospital of 
Kigali, Kigali, Rwanda; Research Directorate (C M Rios González MEd), 
Nihon Gakko University, Fernando de la Mora, Paraguay; Research 
Direction (C M Rios González Med), Universidad Nacional de Caaguazú, 
Coronel Oviedo, Paraguay; Department of Clinical Research 
(L Roever PhD), Federal University of Uberlândia, Uberlândia, Brazil; 
Clinical Epidemiology and Public Health Research Unit (L Ronfani PhD, 
E Traini MSc), Burlo Garofolo Institute for Maternal and Child Health, 
Trieste, Italy; Institute of Epidemiology and Medical Biometry 
(Prof D Rothenbacher MD), Ulm University, Ulm, Germany; Centro de 
Investigación Palmira (E Rubagotti PhD), Agrosavia, Palmira, Colombia; 
Department of Ocean Science and Engineering (E Rubagotti PhD), 
Southern University of Science and Technology, Shenzhen, China; 
Department of Biomedical Sciences (Prof S Rubino PhD), University of 
Sassari, Sassari, Italy; Department of Entomology (A M Samy PhD), 
Department of Neurology (Prof A S Shalash MD), Faculty of Medicine 
(A M Saad MBBCh), Ain Shams University, Cairo, Egypt; 
Nanobiotechnology Center (Prof S Sajadi PhD), Soran University, Soran, 
Iraq; Research Deputy (S Salehi Zahabi PhD), Taleghani Hospital, 
Kermanshah, Iran; Department of Surgery (Prof J Sanabria MD), 
Articles
www.thelancet.com   Published online May 6, 2020   https://doi.org/10.1016/S0140-6736(20)30114-8 21
Marshall University, Huntington, WV, USA; Department of Community 
Medicine (S Y Saraswathy PhD), PSG Institute of Medical Sciences and 
Research, Coimbatore, India; PSG-FAIMER South Asia Regional 
Institute, Coimbatore, India (S Y Saraswathy PhD); Health Economics 
(A R Sarker PhD), Bangladesh Institute of Development Studies (BIDS), 
Dhaka, Bangladesh; Surgery Department (B Sathian PhD), Hamad 
Medical Corporation, Doha, Qatar; Faculty of Health & Social Sciences 
(B Sathian PhD), Bournemouth University, Bournemouth, UK; 
UGC Centre of Advanced Study in Psychology (M Satpathy PhD), 
Utkal University, Bhubaneswar, India; Udyam-Global Association for 
Sustainable Development, Bhubaneswar, India (M Satpathy PhD); 
Department of Medicine (Prof J A Singh MD), Department of 
Psychology (D C Schwebel PhD), University of Alabama at Birmingham, 
Birmingham, AL, USA; Department of Food Science and Nutrition 
(A M Senbeta MS), Jigjiga University, Jigjiga, Ethiopia 
(A A Tassew MPH); Emergency Department (S Senthilkumaran MD), 
Manian Medical Centre, Erode, India; Public Health Division 
(A A Shaheen PhD), An-Najah National University, Nablus, Palestine; 
Independent Consultant, Karachi, Pakistan (M A Shaikh MD); Public 
Health Department (S A Shallo MPH), Ambo University, Ambo, 
Ethiopia; School of Medicine (M Shams-Beyranvand MSc), Dezful 
University of Medical Sciences, Dezful, Iran; School of Medicine 
(M Shams-Beyranvand MSc), Alborz University of Medical Sciences, 
Karaj, Iran; Institute for Population Health (Prof K Shibuya MD), 
King’s College London, London, UK; National Institute of Infectious 
Diseases, Tokyo, Japan (M Shigematsu PhD); Department of Public 
Health (A Shil MPhil), Ben Gurion University of the Negev, Beersheva, 
Israel; Division of Cardiology (Prof J Shin MD), Emory University, 
Atlanta, GA, USA; Finnish Institute of Occupational Health, Helsinki, 
Finland (R Shiri PhD); School of Health (S Siabani PhD), University of 
Technology Sydney, Sydney, NSW, Australia; Medicine Service 
(Prof J A Singh MD), US Department of Veterans Affairs (VA), 
Birmingham, AL, USA; Max Hospital, Ghaziabad, India 
(Prof N P Singh MD); Department of Epidemiology (D N Sinha PhD), 
School of Preventive Oncology, Patna, India; Department of 
Epidemiology (D N Sinha PhD), Healis Sekhsaria Institute for Public 
Health, Mumbai, India; Department of Physiotherapy and Occupational 
Therapy (M M Sisay MPH), Næstved-Slagelse-Ringsted Hospitals, 
Slagelse, Denmark; Department of Infectious Diseases (A Sokhan PhD), 
Kharkiv National Medical University, Kharkiv, Ukraine; Hospital 
Universitario de la Princesa (Prof J B Soriano MD), Autonomous 
University of Madrid, Madrid, Spain; Centro de Investigación Biomédica 
en Red Enfermedades Respiratorias (CIBERES), Madrid, Spain 
(Prof J B Soriano MD); Hull York Medical School (I N Soyiri PhD), 
University of Hull, Hull City, UK; Usher Institute of Population Health 
Sciences and Informatics (I N Soyiri PhD), University of Edinburgh, 
Edinburgh, UK; Division of Community Medicine 
(C T Sreeramareddy MD), International Medical University, Kuala 
Lumpur, Malaysia; Department of Nursing (A Sudaryanto MPH), 
Muhammadiyah University of Surakarta, Surakarta, Indonesia; 
Department of Public Health (A Sudaryanto MPH), China Medical 
University, Taiwan; Department of Criminology, Law and Society 
(Prof B L Sykes PhD), University of California Irvine, Irvine, CA, USA; 
University Institute “Egas Moniz”, Monte da Caparica, Portugal 
(Prof N Taveira PhD); Research Institute for Medicines, Faculty of 
Pharmacy of Lisbon (Prof N Taveira PhD), University of Lisbon, Lisbon, 
Portugal; Colgate University, Hamilton, NY, USA (B Taye PhD); 
South Gate Institute for Health Society and Equity (F H Tesfay MPH), 
Flinders University, Adelaide, SA, Australia; Department of Public 
Health and Community Medicine (Prof K R Thankappan MD), Central 
University of Kerala, Kasaragod, India; Nanyang Technological 
University, Singapore, Singapore (S Thirunavukkarasu PhD); 
Department of Molecular Medicine and Pathology (K B Tran MD), 
University of Auckland, Auckland, New Zealand; Clinical Hematology 
and Toxicology (K B Tran MD), Military Medical University, Hanoi, 
Vietnam; Gomal Center of Biochemistry and Biotechnology 
(I Ullah PhD), Gomal University, Dera Ismail Khan, Pakistan; TB 
Culture Laboratory (I Ullah PhD), Mufti Mehmood Memorial Teaching 
Hospital, Dera Ismail Khan, Pakistan; Department of Community 
Medicine (Prof B Unnikrishnan MD), Manipal Academy of Higher 
Education, Mangalore, India; Clinical Cancer Research Center 
(S Valadan Tahbaz PhD, S Yahyazadeh Jabbari MD), Milad General 
Hospital, Tehran, Iran; Argentine Society of Medicine, Buenos Aires, 
Argentina (Prof P R Valdez MEd); Velez Sarsfield Hospital, Buenos 
Aires, Argentina (Prof P R Valdez MEd); Psychosocial Injuries Research 
Center (Y Veisani PhD), Ilam University of Medical Sciences, Ilam, Iran; 
Occupational Health Unit (Prof F S Violante MD), Sant’Orsola Malpighi 
Hospital, Bologna, Italy; Department of Economics (Prof S Vollmer PhD), 
University of Göttingen, Göttingen, Germany; Foundation University 
Medical College (Y Waheed PhD), Foundation University, Islamabad, 
Pakistan; Department of Epidemiology and Biostatistics (Y Wang BSA, 
Prof C Yu PhD), Global Health Institute (Prof C Yu PhD), Wuhan 
University, Wuhan, China; Competence Center of Mortality-Follow-Up 
of the German National Cohort (R Westerman DSc), Federal Institute for 
Population Research, Wiesbaden, Germany; Department of Physical 
Therapy (T Wiangkham PhD), Naresuan University, Meung District, 
Thailand; Department of Orthopaedics, The Second Affiliated Hospital 
and Yuying Children’s Hospital (Prof A Wu PhD), Wenzhou Medical 
University, Wenzhou, China; School of Medicine (Prof G Xu MD), 
Nanjing University, Nanjing, China; Department of Diabetes and 
Metabolic Diseases (T Yamada MD), University of Tokyo, Tokyo, Japan; 
Centre for Suicide Research and Prevention (Prof P Yip PhD), 
Department of Social Work and Social Administration (Prof P Yip PhD), 
University of Hong Kong, Hong Kong, China; University of South 
Australia, Adelaide, NSW, Australia (B D Yirsaw PhD); Department of 
Psychopharmacology (N Yonemoto MPH), National Center of Neurology 
and Psychiatry, Tokyo, Japan; Department of Health Policy & 
Management (Prof M Z Younis PhD), Jackson State University, Jackson, 
MS, USA; School of Medicine (Prof M Z Younis PhD), Tsinghua 
University, Beijing, China; Department of Health Economics and 
Management (H Yusefzadeh PhD), Urmia University of Medical 
Science, Urmia, Iran; EcoHealth Alliance, New York, NY, USA 
(C Zambrana-Torrelio PhD); Department of Oncology (D Zhang PhD), 
Georgetown University, Washington, DC, USA; Hubei Province Key 
Laboratory of Occupational Hazard Identification and Control 
(Y Zhang PhD), School of Public Health (Y Zhang PhD), Wuhan 
University of Science and Technology, Wuhan, China; Wuhan 
Polytechnic University, Wuhan, China (X Zhao PhD).
Contributors
SIH had the idea for the study. RCR designed and implemented the 
study and wrote the first draft of the report. PAL, MB, and GMG 
obtained, extracted, processed, and geopositioned data. KEW and PAL 
vetted data. KEW wrote the computer code, produced the estimates, 
and vetted models and results, with input from RCR, AD, and SIH. 
LE, MB, CAW, and PAL prepared tables and figures. SBM, PAL, BFB, 
and RCR finalised the report based on comments from other authors 
and reviewers’ feedback. BFB, PAL, and SBM managed the appendix. 
BFB managed the project. All authors provided intellectual inputs into 
aspects of this study. All other authors provided data or developed 
models for indicators, reviewed results, initiated modelling 
infrastructure, or reviewed and contributed to the report.
Declaration of interests
C A T Antonio reports grants and personal fees from Johnson & Johnson 
(Philippines), outside the submitted work. S J Dunachie reports grants 
from The Fleming Fund at UK Department of Health & Social Care, 
during the conduct of the study. M Jakovljevic reports grants from 
Ministry of Education Science and Technological Development of 
The Republic of Serbia, outside the submitted work. J J Jóźwiak reports 
personal fees from ALAB Laboratoria and non-financial support from 
MICROLIFE and SERVIER, outside the submitted work. N Kissoon is 
the Vice President of the GSA and the Canadian Sepsis Foundation. 
W März reports grants from Siemens Healthineers, AstraZeneca, Bayer 
Vital, bestbion dx, Boehringer Ingelheim Pharma, Immundiagnostik, 
Merck Chemicals, MSD, Novartis Pharma, and Olink Proteomics; 
grants and personal fees from Aegerion Pharmaceuticals, AMGEN, 
Sanofi, Alexion Pharmaceuticals, BASF, Abbott Diagnostics, Numares 
AG, Berlin-Chemie, and Akzea Therapeutics; and other from Synlab 
Holding Deutschland, all outside the submitted work. M J Postma 
reports grants and personal fees from various pharmaceutical industries, 
all outside the submitted work; and M J Postma holds stocks in Ingress 
Health and Pharmacoeconomics Advice Groningen (PAG Ltd) and is 
Articles
22 www.thelancet.com   Published online May 6, 2020   https://doi.org/10.1016/S0140-6736(20)30114-8
adviser to Asc Academics, all pharmacoeconomic consultancy 
companies. G Remuzzi reports personal fees and non-financial support 
from Alnylam, Boehringer Ingelheim, Handok Ink, Inception Sciences 
Canada, and Achillion Pharmaceuticals, outside the submitted work. 
J A Singh reports personal fees from Crealta/Horizon, Medisys, Fidia, 
UBM LLC, Medscape, WebMD, Clinical Care options, Clearview 
healthcare partners, Putnam associates, Spherix, the National Institutes 
of Health and the American College of Rheumatology; stock options in 
Amarin pharmaceuticals and Viking pharmaceuticals; and participation 
in the speaker’s bureau of Simply Speaking and in the steering 
committee of OMERACT, an international organisation that develops 
measures for clinical trials and receives arm’s length funding from 
12 pharmaceutical companies, including Amgen, Janssen, Novartis, 
Roche, UCB Group, Ardea/AstraZeneca, Bristol Myers Squibb, Celgene, 
EliLilly, Horizon Pharma, Pfizer, and Centrexion. K Shibuya reports 
grants from Japan Ministry of Health, Labour and Welfare and Japan 
Ministry of Education, Culture, Sports, Science and Technology, during 
the conduct of the study. All other authors declare no competing 
interests.
Data sharing
The source code and data used to generate estimates are available online. 
The full sets of estimates at all geographical levels produced can be 
found online.
Acknowledgments
This work was primarily supported by a grant from the Bill & Melinda 
Gates Foundation (OPP1132415). S Aljunid reports additional funding 
from the International Centre for Casemix and Clinical Coding, Faculty 
of Medicine, National University of Malaysia and Department of Health 
Policy and Management, Faculty of Public Health, Kuwait University for 
the approval and support to participate in this research project outside of 
the study. A Awasthi is supported by the Department of Science and 
Technology, Government of India, New Delhi, through the INSPIRE 
Faculty Program outside of the study. A Badawi reports additional 
funding from the Public Health Agency of Canada outside of the study. 
A Barac reports additional funding from the Project of Ministry of 
Education, Science and Technology of the Republic of Serbia 
(no III45005) outside of the study. T Bärnighausen reports additional 
funding by the Alexander von Humboldt Foundation through the 
Alexander von Humboldt Professor award, funded by the German 
Federal Ministry of Education and Research outside of the study. 
F Carvalho and E Fernandez report additional funding from the 
Portuguese national funds (UID/MULTI/04378/2019 and 
UID/QUI/50006/2019) outside of the study. V M Costa reports additional 
funding from Fundação da Ciência e Tecnologia (FCT) for her grant 
(SFRH/BPD/110001/2015), which was funded by national funds through 
FCT – Fundação para a Ciência e a Tecnologia, IP, under the Norma 
Transitória – DL57/2016/CP1334/CT0006 outside of the study. J De Neve 
reports additional funding from the Alexander von Humboldt 
Foundation outside of the study. K Deribe reports additional funding 
from the Wellcome Trust (grant number 201900) as part of his 
International Intermediate Fellowship outside of the study. D Endalew 
and M Moradi report additional funding from Wolkite University. 
M Ausloos, C Herteliu, and A Pana report additional funding from the 
Romanian National Authority for Scientific Research and Innovation, 
CNDS-UEFISCDI (project number PN-III-P4-ID-PCCF-2016-0084) 
outside of the study. C Herteliu reports additional funding from the 
European Fund for Regional Development through Operational 
Program for Competitiveness (Project ID P_40_382) and the European 
Fund for Regional Development, through InterReg Romania-Hungary 
(project code EMS ROHU 217) outside of the study. P Hoogar reports 
additional funding from the Centre for Holistic Development and 
Research (CHDR), Kalaghatagi and The Department of Studies in 
Anthropology, Karnatak University, D S Islam reports additional funding 
from the National Heart Foundation of Australia and the Institute for 
Physical Activity and Nutrition, Deakin University outside of the study. 
A Khatony reports additional funding from the Clinical Research 
Development Center of Imam Reza Hospital in Kermanshah outside of 
the study. J Khubchandani reports additional funding from Merck 
Research Laboratories outside of the study. K Krishan reports additional 
funding from the UGC Center of Advanced Study (CAS II) awarded to 
the Department of Anthropology, Panjab University, Chandigarh, India 
outside of the study. M Kumar reports additional funding from the 
Fogarty Foundation/NIH through a K43 award (TW010716-01A1) outside 
of the study. B Lacey reports additional funding from the National 
Institute for Health Research Oxford Biomedical Research Centre and 
the British Heart Foundation Centre of Research Excellence (Oxford, 
UK) outside of the study. A M Samy reports additional funding from the 
Egyptian Fulbright Mission Program (EFMP) outside of the study. 
S Seyedmousavi reports additional funding from the Intramural 
Program of National Institute of Health Clinical Center, Bethesda, MD, 
USA outside of the study. M Shey reports additional funding from the 
Wellcome Trust Kenji Shibuya reports additional funding from Japan’s 
Ministry of Health, Labour and Welfare and Japan‘s Ministry of 
Education, Culture, Sport, Science and Technology outside of the study. 
M Sobhiyeh reports additional funding from the Clinical Research 
Development Center of Imam Reza Hospital, Kermanshah University of 
Medical Sciences outside of the study. J Soriano reports additional 
funding from Centro de Investigación en Red de Enfermedades 
Respiratorias (CIBERES), Instituto de Salud Carlos III (ISCIII), Madrid, 
Spain outside of the study. N Taveira reports additional funding from the 
LIFE study (RIA2016MC-1615) of the European and Developing 
Countries Clinical Trials Partnership (EDCTP) program supported by 
the European Union outside of the study. B Unnikrishnan reports 
additional funding from the Kasturba Medical College, Mangalore, 
Manipal Academy of Higher Education, Manipal, India outside of the 
study. T Wijeratne reports additional funding from the Department of 
Medicine, Faculty of Medicine, University of Rajarata, Saliyapura, 
Sri Lanka outside of the study. C S Wiysonge reports additional funding 
from the South African Medical Research Council and the National 
Research Foundation of South Africa outside of the study.
Editorial note: the Lancet Group takes a neutral position with respect to 
territorial claims in published maps and institutional affiliations.
References
1 GBD 2017 Causes of Death Collaborators. Global, regional, 
and national age-sex-specific mortality for 282 causes of death in 
195 countries and territories, 1980–2017: a systematic analysis for 
the Global Burden of Disease Study 2017. Lancet 2018; 
392: 1736–88.
2 GBD 2017 Disease and Injury Incidence and Prevalence 
Collaborators. Global, regional, and national incidence, prevalence, 
and years lived with disability for 354 diseases and injuries for 
195 countries and territories, 1990–2017: a systematic analysis for 
the Global Burden of Disease Study 2017. Lancet 2018; 
392: 1789–858.
3 GBD 2017 Diarrhoeal Disease Collaborators. Quantifying risks and 
interventions that have affected the burden of diarrhoea among 
children younger than 5 years: an analysis of the Global Burden of 
Disease Study 2017. Lancet Infect Dis 2020; 20: 37–59.
4 GBD Diarrhoeal Diseases Collaborators. Estimates of global, 
regional, and national morbidity, mortality, and aetiologies of 
diarrhoeal diseases: a systematic analysis for the Global Burden of 
Disease Study 2015. Lancet Infect Dis 2017; 17: 909–48.
5 WHO, UNICEF. Ending preventable child deaths from pneumonia 
and diarrhoea by 2025: the integrated Global Action Plan for 
Pneumonia and Diarrhoea (GAPPD). 2013 http://www.who.int/
maternal_child_adolescent/documents/global_action_plan_
pneumonia_diarrhoea/en/ (accessed Jan 21, 2020).
6 Walker CLF, Rudan I, Liu L, et al. Global burden of childhood 
pneumonia and diarrhoea. Lancet 2013; 381: 1405–16.
7 Olofin I, McDonald CM, Ezzati M, et al. Associations of suboptimal 
growth with all-cause and cause-specific mortality in children under 
five years: a pooled analysis of ten prospective studies. 
PLoS One 2013; 8: e64636.
8 Troeger C, Khalil IA, Rao PC, et al. Rotavirus vaccination and the 
global burden of rotavirus diarrhea among children younger than 
5 years. JAMA Pediatr 2018; 172: 958–65.
9 Cairncross S, Hunt C, Boisson S, et al. Water, sanitation and 
hygiene for the prevention of diarrhoea. Int J Epidemiol 2010; 
39: i193–205.
10 Munos MK, Walker CLF, Black RE. The effect of oral rehydration 
solution and recommended home fluids on diarrhoea mortality. 
Int J Epidemiol 2010; 39: i75–87.
For the source code and data 
see http://ghdx.healthdata.org/
record/ihme-data/lmic-under-5-
diarrhea-incidence-prevalence-
and-mortality-geospatial-
estimates-2000-2017
For the full sets of estimates see 
https://vizhub.healthdata.org/
lbd/diarrhoea
Articles
www.thelancet.com   Published online May 6, 2020   https://doi.org/10.1016/S0140-6736(20)30114-8 23
11 Pierce N, Sack R, Mitra R, et al. Replacement of water and 
electrolyte losses in cholera by an oral glucose–electrolyte solution. 
Ann Intern Med 1969; 70: 1173–81.
12 Mahalanabis D, Choudhuri A, Bagchi N, Bhattacharya A, 
Simpson T. Oral fluid therapy of cholera among Bangladesh 
refugees. Johns Hopkins Med 1973; 132: 197–205.
13 Mosley WH, Chen LC. An analytical framework for the study of 
child survival in developing countries. Popul Dev Rev 1984; 10: 25–45.
14 Golding N, Burstein R, Longbottom J, et al. Mapping under-5 and 
neonatal mortality in Africa, 2000–15: a baseline analysis for the 
Sustainable Development Goals. Lancet 2017; 390: 2171–82.
15 Osgood-Zimmerman A, Millear AI, Stubbs RW, et al. Mapping 
child growth failure in Africa between 2000 and 2015. Nature 2018; 
555: 41–47.
16 Graetz N, Friedman J, Osgood-Zimmerman A, et al. Mapping local 
variation in educational attainment across Africa. Nature 2018; 
555: 48–53.
17 Annan K. Data can help to end malnutrition across Africa. 
Nature 2018; 555: 7.
18 Bhatt S, Weiss DJ, Cameron E, et al. The effect of malaria control on 
Plasmodium falciparum in Africa between 2000 and 2015. 
Nature 2015; 526: 207–11.
19 Mosser JF, Gagne-Maynard W, Rao PC, et al. Mapping 
diphtheria-pertussis-tetanus vaccine coverage in Africa, 2000–2016: 
a spatial and temporal modelling study. Lancet 2019; 393: 1843–55.
20 Wiens KE, Hay SI, Reiner RC Jr, et al. Mapping geographical 
inequalities in oral rehydration therapy coverage in low-income 
and middle-income countries, 2000–17. Lancet Glob Health 
(in press). 
21 Reiner RC, Graetz N, Casey DC, et al. Variation in childhood 
diarrheal morbidity and mortality in Africa, 2000–2015. 
N Engl J Med 2018; 379: 1128–38.
22 Wolf J, Hunter PR, Freeman MC, et al. Impact of drinking water, 
sanitation and handwashing with soap on childhood diarrhoeal 
disease: updated meta-analysis and meta-regression. 
Trop Med Int Health 2018; 23: 508–25.
23 Wilson SE, Morris SS, Gilbert SS, et al. Scaling up access to oral 
rehydration solution for diarrhea: learning from historical 
experience in low- and high-performing countries. 
J Glob Health 2013; 3: 010404.
24 GBD 2017 Mortality Collaborators. Global, regional, and national 
age-sex-specific mortality and life expectancy, 1950–2017: 
a systematic analysis for the Global Burden of Disease Study 2017. 
Lancet 2018; 392: 1684–735.
25 Stevens GA, Alkema L, Black RE, et al. Guidelines for Accurate and 
Transparent Health Estimates Reporting: the GATHER statement. 
Lancet 2016; 388: e19–23.
26 GBD 2016 Healthcare Access and Quality Collaborators. 
Measuring performance on the Healthcare Access and Quality 
Index for 195 countries and territories and selected subnational 
locations: a systematic analysis from the Global Burden of Disease 
Study 2016. Lancet 2018; 391: 2236–71.
27 Faraway JJ. Linear models with R: chapter 4, problems with the 
predictors. Boca Raton: CRC Press, 2004.
28 Bhatt S, Cameron E, Flaxman SR, Weiss DJ, Smith DL, Gething PW. 
Improved prediction accuracy for disease risk mapping using 
Gaussian process stacked generalization. J R Soc Interface 2017; 
14: 20170520.
29 Martins TG, Simpson D, Lindgren F, Rue H. Bayesian computing 
with INLA: new features. Comput Stat Data Anal 2013; 67: 68–83.
30 Rue H, Martino S, Chopin N. Approximate Bayesian inference for 
latent Gaussian models by using integrated nested Laplace 
approximations. J R Stat Soc Series B Stat Methodol 2009; 71: 319–92.
31 Murray CJL, Ezzati M, Flaxman AD, et al. GBD 2010: design, 
definitions, and metrics. Lancet 2012; 380: 2063–66.
32 De Maio FG. Income inequality measures. J Epidemiol Community 
Health 2007; 61: 849.
33 GeoNetwork. The Global Administrative Unit Layers (GAUL). 2015. 
http://www.fao.org/geonetwork/srv/en/metadata.show?id=12691 
(accessed June 1, 2017).
34 Land Processes Distributed Active Archive Center. Combined 
MODIS 5.1. MCD12Q1 | LP DAAC:: NASA Land Data Products and 
Services. 2017; published online June 1. https://lpdaac.usgs.gov/
products/mcd12q1v006/ (accessed June 1, 2017).
35 World Wildlife Fund. Global lakes and wetlands database, level 3. 
July 1, 2004. https://www.worldwildlife.org/publications/global-
lakes-and-wetlands-database-lakes-and-wetlands-grid-level-3 
(accessed Jan 21, 2020).
36 WorldPop. Data types. https://www.worldpop.org/project/list 
(accessed Jan 21, 2020).
37 Tatem AJ. WorldPop, open data for spatial demography. Sci Data 2017; 
4: 170004.
38 Lehner B, Döll P. Development and validation of a global database 
of lakes, reservoirs and wetlands. J Hydrol 2004; 296: 1–22.
39 Bhattacharjee NV, Schaeffer LE, Marczak LB, et al. Mapping exclusive 
breastfeeding in Africa between 2000 and 2017. Nat Med 2019; 
25: 1205–12.
